FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Chung, JE
   Magis, W
   Vu, J
   Heo, SJ
   Wartiovaara, K
   Walters, MC
   Kurita, R
   Nakamura, Y
   Boffelli, D
   Martin, DIK
   Corn, JE
   Dewitt, MA
AF Chung, Jennifer E.
   Magis, Wendy
   Vu, Jonathan
   Heo, Seok-Jin
   Wartiovaara, Kirmo
   Walters, Mark C.
   Kurita, Ryo
   Nakamura, Yukio
   Boffelli, Dario
   Martin, David I. K.
   Corn, Jacob E.
   Dewitt, Mark A.
TI CRISPR-Cas9 interrogation of a putative fetal globin repressor in human
   erythroid cells
SO PLOS ONE
LA English
DT Article
ID HEMOGLOBIN; DISEASE; GENE; LIFE
AB Sickle Cell Disease and beta-thalassemia, which are caused by defective or deficient adult beta-globin (HBB) respectively, are the most common serious genetic blood diseases in the world. Persistent expression of the fetal beta-like globin, also known gamma-globin, can ameliorate both disorders by serving in place of the adult beta-globin as a part of the fetal hemoglobin tetramer (HbF). Here we use CRISPR-Cas9 gene editing to explore a potential gamma-globin silencer region upstream of the delta-globin gene identified by comparison of naturally-occurring deletion mutations associated with up-regulated gamma-globin. We find that deletion of a 1.7 kb consensus element or select 350 bp sub-regions from bulk populations of cells increases levels of HbF. Screening of individual sgRNAs in one sub-region revealed three single guides that caused increases gamma-globin expression. Deletion of the 1.7 kb region in HUDEP-2 clonal sublines, and in colonies derived from CD34+ hematopoietic stem/progenitor cells (HSPCs), does not cause significant up-regulation of gamma-globin. These data suggest that the 1.7 kb region is not an autonomous gamma-globin silencer, and thus by itself is not a suitable therapeutic target for gene editing treatment of beta-hemoglobinopathies.
C1 [Chung, Jennifer E.; Vu, Jonathan; Corn, Jacob E.; Dewitt, Mark A.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.
   [Magis, Wendy; Heo, Seok-Jin; Wartiovaara, Kirmo; Walters, Mark C.; Boffelli, Dario; Martin, David I. K.] UCSF Benioff Childrens Hosp, Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA.
   [Wartiovaara, Kirmo] Univ Helsinki, Res Programs Unit, Mol Neurol & Biomedicum Stem Cell Ctr, Fac Med, Helsinki, Finland.
   [Wartiovaara, Kirmo] Univ Helsinki, Clin Genet, HUSLAB, Cent Hosp, Helsinki, Finland.
   [Walters, Mark C.] UCSF Benioff Childrens Hosp, Div Hematol, Blood & Marrow Transplant Program, Oakland, CA USA.
   [Kurita, Ryo; Nakamura, Yukio] RIKEN, BioResource Ctr, Cell Engn Div, Tsukuba, Ibaraki, Japan.
   [Nakamura, Yukio] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan.
   [Corn, Jacob E.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA.
RP Corn, JE; Dewitt, MA (reprint author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Martin, DIK (reprint author), UCSF Benioff Childrens Hosp, Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA.; Corn, JE (reprint author), Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA.
EM dimartin@chori.org; jcorn@berkeley.edu; dewittm@berkeley.edu
RI Nakamura, Yukio/A-5263-2016
OI Chung, Jennifer/0000-0003-1332-6301; Vu, Jonathan/0000-0002-4950-7967
FU NIH [S10 OD018174]; Li Ka Shing Foundation; Heritage Medical Research
   Institute; California Institute of Regenerative Medicine; Siebel
   foundation; Lam foundation; Jordan Family Foundation
FX This work used the Vincent J. Coates Genomics Sequencing Laboratory at
   UC Berkeley, supported by NIH S10 OD018174 Instrumentation Grant.
   Synthetic RNAs for studies presented in Figure 3D were obtained from
   Synthego, Inc. through their 2017 Synthego Grant Program (MAD). This
   work was supported by the Li Ka Shing Foundation (JEC), the Heritage
   Medical Research Institute (JEC), the California Institute of
   Regenerative Medicine (MAD, JEC), the Siebel foundation (MAD), the Lam
   foundation (J. Chung), and the Jordan Family Foundation (DKM). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.; This work used
   the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley,
   supported by NIH S10 OD018174 Instrumentation Grant. Synthetic RNAs for
   studies presented in Fig 3D were provided by Synthego, Inc. This work
   was supported by the Li Ka Shing Foundation (J.E.C.), the Heritage
   Medical Research Institute (J.E.C.), the California Institute of
   Regenerative Medicine (M.A.D., J.E.C.), the Siebel foundation (M.A.D.),
   the Lam foundation (J. Chung), and the Jordan Family Foundation
   (D.I.K.M.).
CR Antoniani C, 2018, BLOOD, DOI [10.1182/blood-2017-10-811505, 10.1182/blood-2003-11-4069, DOI 10.1182/BLOOD-2017-10-811505]
   Appelbaum FR, 2009, THOMAS HEMATOPOIETIC, DOI [10.1002/9781444303537, DOI 10.1002/9781444303537]
   Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d
   Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521
   Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418
   Chakalova L, 2005, BLOOD, V105, P2154, DOI 10.1182/blood-2003-11-4069
   Charlesworth CT, 2018, BIORXIV, DOI [10.1101/243345, DOI 10.1101/243345]
   Davis Bruce H, 2004, Curr Protoc Cytom, VChapter 6, DOI 10.1002/0471142956.cy0617s28
   DeWitt MA, 2017, METHODS, V121, P9, DOI 10.1016/j.ymeth.2017.04.003
   DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336
   Elmariah H, 2014, AM J HEMATOL, V89, P530, DOI 10.1002/ajh.23683
   Feingold EA, 1999, GENOMICS, V61, P15, DOI 10.1006/geno.1999.5935
   Hardison RC, 2002, HUM MUTAT, V19, P225, DOI 10.1002/humu.10044
   Hoban MD, 2016, BLOOD
   Huang P, 2017, GENE DEV, V31, P1704, DOI 10.1101/gad.303461.117
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686
   Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192
   Kurita R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059890
   Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766
   Lingeman Emily, 2017, Curr Protoc Mol Biol, V120, DOI 10.1002/cpmb.43
   Liu N, 2018, CELL, V173, P430, DOI 10.1016/j.cell.2018.03.016
   Long J, 2018, MOL THER, V26, P468, DOI 10.1016/j.ymthe.2017.11.001
   McGann PT, 2017, BLOOD, V129, P155, DOI 10.1182/blood-2016-09-702324
   Panepinto JA, 2012, PEDIATR BLOOD CANCER, V59, P377, DOI 10.1002/pbc.24176
   Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/NMETH.2639, 10.1038/nmeth.2639]
   PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303
   Sankaran VG, 2011, NEW ENGL J MED, V365, P807, DOI 10.1056/NEJMoa1103070
   Traxler EA, 2016, NAT MED, V22, P987, DOI 10.1038/nm.4170
   Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105
   Ware RE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002120
   Wienert B, 2017, BLOOD, V130, P803, DOI 10.1182/blood-2017-02-767400
   Wienert B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8085
   Williams TN, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011692
   Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053
   Ye L, 2016, P NATL ACAD SCI USA, V113, P10661, DOI 10.1073/pnas.1612075113
NR 37
TC 0
Z9 0
U1 5
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 15
PY 2019
VL 14
IS 1
AR e0208237
DI 10.1371/journal.pone.0208237
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HH6AH
UT WOS:000455810200005
PM 30645582
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Castel, B
   Tomlinson, L
   Locci, F
   Yang, Y
   Jones, JDG
AF Castel, Baptiste
   Tomlinson, Laurence
   Locci, Federica
   Yang, Ying
   Jones, Jonathan D. G.
TI Optimization of T-DNA architecture for Cas9-mediated mutagenesis in
   Arabidopsis
SO PLOS ONE
LA English
DT Article
ID TARGETED MUTAGENESIS; GENE-EXPRESSION; HIGH-EFFICIENCY; GENOME; CAS9;
   CRISPR/CAS9; PROMOTER; RECOMBINATION; SPECIFICITY; NUCLEASES
AB Bacterial CRISPR systems have been widely adopted to create operator-specified site-specific nucleases. Such nuclease action commonly results in loss-of-function alleles, facilitating functional analysis of genes and gene families We conducted a systematic comparison of components and T-DNA architectures for CRISPR-mediated gene editing in Arabidopsis, testing multiple promoters, terminators, sgRNA backbones and Cas9 alleles. We identified a T-DNA architecture that usually results in stable (i.e. homozygous) mutations in the first generation after transformation. Notably, the transcription of sgRNA and Cas9 in head-to-head divergent orientation usually resulted in highly active lines. Our Arabidopsis data may prove useful for optimization of CRISPR methods in other plants.
C1 [Castel, Baptiste; Tomlinson, Laurence; Locci, Federica; Yang, Ying; Jones, Jonathan D. G.] Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England.
   [Locci, Federica] Sapienza Univ Rome, Dept Biol & Biotechnol Charles Darwin, Rome, Italy.
   [Yang, Ying] Univ Lincoln, Beadle Ctr, Ctr Plant Sci Innovat, Lincoln, NE USA.
RP Jones, JDG (reprint author), Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England.
EM jonathan.jones@tsl.ac.uk
OI Castel, Baptiste/0000-0002-2722-0228
FU Gatsby Charitable Foundation at The Sainsbury Laboratory, Norwich; Bill
   and Melinda Gates Foundation (Grand Challenges Exploration)
   [OPP1060026]; Sapienza University of Rome; Gatsby Charitable Foundation
   at The Sainsbury Laboratory
FX This work was supported by the Gatsby Charitable Foundation at The
   Sainsbury Laboratory, Norwich, and the Bill and Melinda Gates Foundation
   (Grand Challenges Exploration, grant agreement OPP1060026). Federica
   Locci was supported by the "Funding of joint research projects for the
   PhD students' mobility abroad" from Sapienza University of Rome. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.; This work was
   supported by the Gatsby Charitable Foundation at The Sainsbury
   Laboratory and the Bill and Melinda Gates Foundation (Grand Challenges
   Exploration, grant agreement OPP1060026). Federica LOCCI was supported
   by the "Funding of joint research projects for the PhD students'
   mobility abroad" from Sapienza University of Rome. We thank Dr Sylvestre
   Marillonnet for help refining Golden Gate cloning vectors.
CR Barrangou R, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.92
   CALLIS J, 1987, GENE DEV, V1, P1183, DOI 10.1101/gad.1.10.1183
   Cermak T, 2017, PLANT CELL, V29, P1196, DOI 10.1105/tpc.16.00922
   Cermak T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0796-9
   Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001
   Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Eid A, 2016, PLANT CELL REP, V35, P1555, DOI 10.1007/s00299-016-2000-4
   Engler C, 2014, ACS SYNTH BIOL, V3, P839, DOI 10.1021/sb4001504
   Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554
   Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111
   Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152
   Gisler B, 2002, PLANT J, V32, P277, DOI 10.1046/j.1365-313X.2002.01421.x
   Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321
   Hayut SF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15605
   Hong RL, 2003, PLANT CELL, V15, P1296, DOI 10.1105/tpc.009548
   Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010
   Hyun Y, 2015, PLANTA, V241, P271, DOI 10.1007/s00425-014-2180-5
   Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780
   Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Lawrenson T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0826-7
   LeBlanc C, 2018, PLANT J, V93, P377, DOI [10.1111/tpj.13828, 10.1111/tpj.13782]
   Li X, 2007, J INTEGR PLANT BIOL, V49, P222, DOI 10.1111/j.1672-9072.2007.00393.x
   Li ZS, 2015, PLANT PHYSIOL, V169, P960, DOI 10.1104/pp.15.00783
   Liang Z, 2018, NAT PROTOC, V13, P413, DOI 10.1038/nprot.2017.145
   Makarova KS, 2017, CELL, V168, P946, DOI [10.1016/j.cell.2016.12.038, 10.1016/j.cell.2017.02.018]
   Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Morineau C, 2017, PLANT BIOTECHNOL J, V15, P729, DOI 10.1111/pbi.12671
   Nagaya S, 2010, PLANT CELL PHYSIOL, V51, P328, DOI 10.1093/pcp/pcp188
   Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655
   PERALTA EG, 1986, EMBO J, V5, P1137, DOI 10.1002/j.1460-2075.1986.tb04338.x
   Peterson BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162169
   Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650
   Shimada TL, 2010, PLANT J, V61, P519, DOI 10.1111/j.1365-313X.2009.04060.x
   Sunilkumar G, 2002, PLANT MOL BIOL, V50, P463, DOI 10.1023/A:1019832123444
   Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793
   Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908
   Tsutsui H, 2017, PLANT CELL PHYSIOL, V58, P46, DOI 10.1093/pcp/pcw191
   WAIBEL F, 1990, NUCLEIC ACIDS RES, V18, P3451, DOI 10.1093/nar/18.12.3451
   Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0
   Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765
   Woo JW, 2015, NAT BIOTECHNOL, P10
   Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035
   Wu R, 2018, BIOMED CENTRAL, V14, P65, DOI [10.1186/s13007-018-0330-7, DOI 10.1186/S13007-018-0330-7]
   Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112
   Yan LH, 2015, MOL PLANT, V8, P1820, DOI 10.1016/j.molp.2015.10.004
NR 49
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 9
PY 2019
VL 14
IS 1
AR e0204778
DI 10.1371/journal.pone.0204778
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HG9VK
UT WOS:000455359400006
PM 30625150
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Wu, K
   Shirk, PD
   Taylor, CE
   Furlong, RB
   Shirk, BD
   Pinheiro, DH
   Siegfried, BD
AF Wu, Ke
   Shirk, Paul D.
   Taylor, Caitlin E.
   Furlong, Richard B.
   Shirk, Bryce D.
   Pinheiro, Daniele H.
   Siegfried, Blair D.
TI CRISPR/Cas9 mediated knockout of the abdominal-A homeotic gene in fall
   armyworm moth (Spodoptera frugiperda)
SO PLOS ONE
LA English
DT Article
ID FIELD-EVOLVED RESISTANCE; ABD-A; INSECTICIDE RESISTANCE;
   LEPIDOPTERA-NOCTUIDAE; BITHORAX-COMPLEX; RNA INTERFERENCE; DROSOPHILA;
   REQUIRES; MUTAGENESIS; SILKWORM
AB The fall armyworm (FAW), Spodoptera frugiperda (J.E. Smith), is an important pest of maize in the Americas and has recently been introduced into Africa. Fall armyworm populations have developed resistance to control strategies that depend on insecticides and transgenic plants expressing Bacillus thuringiensis toxins. The study of various resistance mechanisms at the molecular level and the development novel control strategies have been hampered by a lack of functional genomic tools such as gene editing in this pest. In the current study, we explored the possibility of using the CRISPR/Cas9 system to modify the genome of FAW. We first identified and characterized the abdominal-A (Sfabd-A) gene of FAW. Sfabd-A single guide RNA (sgRNA) and Cas9 protein were then injected into 244 embryos of FAW. Sixty-two embryos injected with Sfabd-A sgRNA hatched. Of these hatched embryos, twelve developed into larvae that displayed typical aba-A mutant phenotypes such as fused segments. Of the twelve mutant larvae, three and five eventually developed into female and male moths, respectively. Most mutant moths were sterile, and one female produced a few unviable eggs when it was outcrossed to a wild-type male. Genotyping of 20 unhatched Sfabd-A sgRNA-injected embryos and 42 moths that developed from Sfabd-A sgRNA-injected embryos showed that 100% of the unhatched embryos and 50% of the moths contained indel mutations at the Sfabd-A genomic locus near the guide RNA target site. These results suggest that the CRISPR/Cas9 system is highly efficient in editing FAW genome. Importantly, this gene editing technology can be used to validate gene function to facilitate an understanding of the resistance mechanism and lead to the development of novel pest management approaches.
C1 [Wu, Ke; Taylor, Caitlin E.; Pinheiro, Daniele H.; Siegfried, Blair D.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.
   [Shirk, Paul D.; Furlong, Richard B.; Shirk, Bryce D.] USDA ARS, CMAVE IBBRU, Gainesville, FL USA.
RP Wu, K (reprint author), Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.
EM kewu@ufl.edu
OI Wu, Ke/0000-0002-4438-1517
CR Banerjee R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09866-y
   Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020
   Bi HL, 2016, INSECT SCI, V23, P469, DOI 10.1111/1744-7917.12341
   BUSTURIA A, 1989, DEVELOPMENT, V107, P575
   Chandrasena DI, 2018, PEST MANAG SCI, V74, P746, DOI 10.1002/ps.4776
   Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   CUMBERLEDGE S, 1992, DEVELOPMENT, V115, P395
   Deng HM, 2012, P NATL ACAD SCI USA, V109, P12598, DOI 10.1073/pnas.1203149109
   Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019
   Flagel L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25491-9
   Foronda D, 2006, DEVELOPMENT, V133, P117, DOI 10.1242/dev.02173
   Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945
   Gilles AF, 2015, DEVELOPMENT, V142, P2832, DOI 10.1242/dev.125054
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850
   Huang YP, 2016, INSECT BIOCHEM MOLEC, V75, P98, DOI 10.1016/j.ibmb.2016.06.004
   Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Khan SA, 2017, SCI REP-UK, V7, DOI 10.1038/srep40025
   Li GP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154492
   Li XY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9212
   Lovato TL, 2002, DEVELOPMENT, V129, P5019
   Marchetti M, 2003, DEVELOPMENT, V130, P3683, DOI 10.1242/dev.00587
   MATHIES LD, 1994, DEVELOPMENT, V120, P2799
   MICHELSON AM, 1994, DEVELOPMENT, V120, P755
   Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319
   Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755
   Pan MH, 2009, INSECT MOL BIOL, V18, P155, DOI 10.1111/j.1365-2583.2009.00862.x
   Perera OP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197567
   Perrin L, 2004, DEV BIOL, V272, P419, DOI 10.1016/j.ydbio.2004.04.036
   Ponzielli R, 2002, DEVELOPMENT, V129, P4509
   Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395
   Prasanna BM, 2018, FALL ARMYWORM AFRICA, P120
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Rezsohazy R, 2015, DEVELOPMENT, V142, P1212, DOI 10.1242/dev.109785
   SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0
   Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542
   Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040
   Suzuki T, 2010, PESTIC BIOCHEM PHYS, V97, P199, DOI 10.1016/j.pestbp.2010.01.005
   Suzuki T, 2009, J INSECT PHYSIOL, V55, P250, DOI 10.1016/j.jinsphys.2008.11.014
   Taning CNT, 2017, J INSECT PHYSIOL, V98, P245, DOI 10.1016/j.jinsphys.2017.01.007
   Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006
   Wang YQ, 2013, CELL RES, V23, P1414, DOI 10.1038/cr.2013.146
   Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951
   Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853
   Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773
   Wu K, 2012, J INVERTEBR PATHOL, V109, P20, DOI 10.1016/j.jip.2011.09.005
   Xue WH, 2018, INSECT BIOCHEM MOLEC, V93, P19, DOI 10.1016/j.ibmb.2017.12.003
   Yoon JS, 2017, INSECT BIOCHEM MOLEC, V90, P53, DOI 10.1016/j.ibmb.2017.09.011
   Yu SJ, 2003, PESTIC BIOCHEM PHYS, V77, P1, DOI 10.1016/S0048-3575(03)00079-8
   YU SJ, 1991, PESTIC BIOCHEM PHYS, V39, P84, DOI 10.1016/0048-3575(91)90216-9
NR 54
TC 0
Z9 0
U1 9
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 6
PY 2018
VL 13
IS 12
AR e0208647
DI 10.1371/journal.pone.0208647
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HD1YF
UT WOS:000452307600101
PM 30521608
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Stratigopoulos, G
   De Rosa, MC
   LeDuc, CA
   Leibel, RL
   Doege, CA
AF Stratigopoulos, George
   De Rosa, Maria Caterina
   LeDuc, Charles A.
   Leibel, Rudolph L.
   Doege, Claudia A.
TI DMSO increases efficiency of genome editing at two non-coding loci
SO PLOS ONE
LA English
DT Article
ID HUMAN-CELLS; GENE; RNA; DNA; CRISPR/CAS9; DELIVERY; SYSTEM; CAS9; MICE;
   FTO
AB Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein-9 (Cas9) has become the tool of choice for genome editing. Despite the fact that it has evolved as a highly efficient means to edit/replace coding sequence, CRISPR/Cas9 efficiency for "clean" editing of non-coding DNA remains low. We set out to introduce a single base-pair substitution in two intronic SNPs at the FTO locus without altering nearby non-coding sequence. Substitution efficiency increased up to 10-fold by treatment of human embryonic stem cells (ESC) with non-toxic levels of DMSO (1%) before CRISPR/Cas9 delivery. Treatment with DMSO did not result in CRISPR/Cas9 off-target effects or compromise the chromosomal stability of the ESC. Twenty-four hour treatment of human ESC with DMSO before CRISPR/Cas9 delivery may prove a simple means to increase editing efficiency of non-coding DNA without incorporation of undesirable mutations.
C1 [Stratigopoulos, George; De Rosa, Maria Caterina; LeDuc, Charles A.; Leibel, Rudolph L.] Columbia Univ, Dept Pediat, New York, NY 10027 USA.
   [Stratigopoulos, George; De Rosa, Maria Caterina; LeDuc, Charles A.; Leibel, Rudolph L.; Doege, Claudia A.] Columbia Univ, Naomi Berrie Diabet Ctr, Med Ctr, New York, NY 10027 USA.
   [De Rosa, Maria Caterina; Doege, Claudia A.] Columbia Univ, Columbia Stem Cell Initiat, Med Ctr, New York, NY USA.
   [LeDuc, Charles A.; Leibel, Rudolph L.; Doege, Claudia A.] Columbia Univ, New York Obes Nutr Res Ctr, New York, NY USA.
   [Leibel, Rudolph L.] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA.
   [Doege, Claudia A.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA.
RP Stratigopoulos, G (reprint author), Columbia Univ, Dept Pediat, New York, NY 10027 USA.; Stratigopoulos, G (reprint author), Columbia Univ, Naomi Berrie Diabet Ctr, Med Ctr, New York, NY 10027 USA.
EM gs2172@cumc.columbia.edu
OI Stratigopoulos, George/0000-0003-4752-9123
FU Naomi Berrie Obesity-Neuroscience Initiative pilot grant [DK52431]; MBMG
   core of the NYNORC [5P30DK026687]
FX Work was funded by a Naomi Berrie Obesity-Neuroscience Initiative pilot
   grant awarded to GS and DK52431 awarded to RLL. CAL, RLL and CAD work
   for the MBMG core of the NYNORC (grant 5P30DK026687). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Buchschacher GL, 2000, BLOOD, V95, P2499
   Canver MC, 2017, METHODS, V121, P118, DOI 10.1016/j.ymeth.2017.03.008
   Chakrabarti R, 2001, GENE, V274, P293, DOI 10.1016/S0378-1119(01)00621-7
   Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001
   Chetty S, 2013, NAT METHODS, V10, P553, DOI [10.1038/NMETH.2442, 10.1038/nmeth.2442]
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Czysz K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117689
   Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3
   Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006
   Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004
   Iwatani M, 2006, STEM CELLS, V24, P2549, DOI 10.1634/stemcells.2005-0427
   Jiang C, 2017, CELL RES, V27, P440, DOI 10.1038/cr.2017.16
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Montgomery JL, 2014, J MOL DIAGN, V16, P305, DOI 10.1016/j.jmoldx.2014.01.006
   Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664
   Peters U, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003171
   Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021
   Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002
   Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115
   Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007
   Stratigopoulos G, 2016, J CLIN INVEST, V126, P1897, DOI 10.1172/JCI85526
   Stratigopoulos G, 2014, CELL METAB, V19, P767, DOI 10.1016/j.cmet.2014.04.009
   Stratigopoulos G, 2011, J BIOL CHEM, V286, P2155, DOI 10.1074/jbc.M110.188482
   Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565
   TAKASE K, 1992, CELL GROWTH DIFFER, V3, P515
   Thaler R, 2012, EPIGENETICS-US, V7, P635, DOI 10.4161/epi.20163
   Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889
   Yang D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21264
   Zhang Z, 2017, MOL THER-NUCL ACIDS, V9, P230, DOI 10.1016/j.omtn.2017.09.009
   Zufferey R, 1998, J VIROL, V72, P9873
NR 35
TC 2
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 4
PY 2018
VL 13
IS 6
AR e0198637
DI 10.1371/journal.pone.0198637
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GI0YU
UT WOS:000434097100040
PM 29864154
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Breunig, CT
   Durovic, T
   Neuner, AM
   Baumann, V
   Wiesbeck, MF
   Koferle, A
   Gotz, M
   Ninkovic, J
   Stricker, SH
AF Breunig, Christopher T.
   Durovic, Tamara
   Neuner, Andrea M.
   Baumann, Valentin
   Wiesbeck, Maximilian F.
   Koeferle, Anna
   Goetz, Magdalena
   Ninkovic, Jovica
   Stricker, Stefan H.
TI One step generation of customizable gRNA vectors for multiplex CRISPR
   approaches through string assembly gRNA cloning (STAgR)
SO PLOS ONE
LA English
DT Article
ID GENOME; SYSTEM; GENES; CELLS
AB Novel applications based on the bacterial CRISPR system make genetic, genomic, transcriptional and epigenomic engineering widely accessible for the first time. A significant advantage of CRISPR over previous methods is its tremendous adaptability due to its bipartite nature. Cas9 or its engineered variants define the molecular effect, while short gRNAs determine the targeting sites. A majority of CRISPR approaches depend on the simultaneous delivery of multiple gRNAs into single cells, either as an essential precondition, to increase responsive cell populations or to enhance phenotypic outcomes. Despite these requirements, methods allowing the efficient generation and delivery of multiple gRNA expression units into single cells are still sparse. Here we present STAgR (String assembly gRNA cloning), a single step gRNA multiplexing system, that obtains its advantages by employing the N20 targeting sequences as necessary homologies for Gibson assembly. We show that STAgR allows reliable and cost-effective generation of vectors with high numbers of gRNAs enabling multiplexed CRISPR approaches. Moreover, STAgR is easily customizable, as vector backbones as well as gRNA structures, numbers and promoters can be freely chosen and combined. Finally, we demonstrate STAgR's widespread functionality, its efficiency in multi-targeting approaches, using it for both, genome and transcriptome editing, as well as applying it in vitro and in vivo.
C1 [Breunig, Christopher T.; Neuner, Andrea M.; Baumann, Valentin; Wiesbeck, Maximilian F.; Koeferle, Anna; Stricker, Stefan H.] Ludwig Maximilians Univ Munchen, Munich Ctr Neurosci, MCN Jr Res Grp, BioMed Ctr, Planegg Martinsried, Germany.
   [Breunig, Christopher T.; Stricker, Stefan H.] Helmholtz Zentrum, German Res Ctr Environm Hlth, Inst Stem Cell Res, Epigenet Engn, Planegg Martinsried, Germany.
   [Durovic, Tamara; Baumann, Valentin] Ludwig Maximilians Univ Munchen, Grad Sch System Neurosci, Munich, Germany.
   [Durovic, Tamara; Ninkovic, Jovica] Helmholtz Zentrum, German Res Ctr Environm Hlth, Inst Stem Cell Res, Neurogenesis & Regenerat, Neuherberg, Germany.
   [Goetz, Magdalena] Helmholtz Zentrum, German Res Ctr Environm Hlth, Inst Stem Cell Res, Neural Stem cells, Neuherberg, Germany.
   [Goetz, Magdalena; Ninkovic, Jovica] Ludwig Maximilians Univ Munchen, BioMed Ctr, Physiol Genom, Planegg Martinsried, Germany.
RP Stricker, SH (reprint author), Ludwig Maximilians Univ Munchen, Munich Ctr Neurosci, MCN Jr Res Grp, BioMed Ctr, Planegg Martinsried, Germany.; Stricker, SH (reprint author), Helmholtz Zentrum, German Res Ctr Environm Hlth, Inst Stem Cell Res, Epigenet Engn, Planegg Martinsried, Germany.
EM stricker@biologie.uni-muenchen.de
RI Stricker, Stefan H/A-4930-2015
OI Stricker, Stefan H/0000-0002-5488-8530; Koferle,
   Anna/0000-0003-1601-7774
FU Deutsche Forschungsgemeinschaft [STR 1385/1-1]
FX CB, AN, VB, MW, AK and SHS were supported by Deutsche
   Forschungsgemeinschaft (STR 1385/1-1) (http://www.dfg.de/). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Balboa D, 2015, STEM CELL REP, V5, P448, DOI 10.1016/j.stemcr.2015.08.001
   Barbosa JS, 2016, NAT PROTOC, V11, P1360, DOI 10.1038/nprot.2016.077
   Barbosa JS, 2015, SCIENCE, V348, P789, DOI 10.1126/science.aaa2729
   Black JB, 2016, CELL STEM CELL, V19, P406, DOI 10.1016/j.stem.2016.07.001
   Chakraborty S, 2014, STEM CELL REP, V3, P940, DOI 10.1016/j.stemcr.2014.09.013
   Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Ferreira R, 2018, ACS SYNTH BIOL, V7, P10, DOI 10.1021/acssynbio.7b00259
   Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]
   Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199
   Jiang JF, 2016, SCI REP-UK, V6, DOI 10.1038/srep21918
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749
   Kalhor R, 2017, NAT METHODS, V14, P195, DOI [10.1038/NMETH.4108, 10.1038/nmeth.4108]
   Kizil C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027395
   Koeferle A, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0185-8
   Koferle A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3268-z
   Koferle A, J VISUALIZE IN PRESS
   Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136
   Ledford H, 2016, NATURE, V531, P156, DOI 10.1038/531156a
   Lekomtsev S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3084-5
   Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]
   Port F, 2016, NAT METHODS, V13, P852, DOI 10.1038/nmeth.3972
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400
   Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]
   Stricker SH, 2017, NAT REV GENET, V18, P51, DOI 10.1038/nrg.2016.138
   Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025
   Wang LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17517
   Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112
   Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134
   Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022
   Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120396
NR 34
TC 5
Z9 5
U1 2
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 27
PY 2018
VL 13
IS 4
AR e0196015
DI 10.1371/journal.pone.0196015
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GE1YS
UT WOS:000431013300014
PM 29702666
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Wu, YM
   Luna, MJ
   Bonilla, LS
   Ryba, NJP
   Pickel, JM
AF Wu, Youmei
   Luna, Maria Jose
   Bonilla, Lauren S.
   Ryba, Nicholas J. P.
   Pickel, James M.
TI Characterization of knockin mice at the Rosa26, Tac1 and Plekhg1 loci
   generated by homologous recombination in oocytes
SO PLOS ONE
LA English
DT Article
ID RABIES VIRUS; WEB TOOL; GENOME; CRISPR/CAS9; EFFICIENCY; CHOPCHOP;
   SYSTEMS; SWEET; TASTE; RATS
AB Design and engineering of complex knockin mice has revolutionized the in vivo manipulation of genetically defined cells. Recently development of the bacterial clustered regularly interspersed short palindromic repeats (CRISPR) associated protein 9 (Cas9) system for single site cleavage of mammalian genomes has opened the way for rapid generation of knockin mice by targeting homology directed repair to selected cleavage sites. We used this approach to generate new lines of mice that will be useful for a variety of aspects of neuroscience research. These lines have been bred to homozygosity and details of the expression and function of the transgenes are reported. Two lines target the Rosa26-locus and have been engineered to allow Cre-dependent expression of the avian tva receptor, and Cre-dependent expression of a cell surface targeted spaghetti-monster carrying many copies of the "ollas-tag". Another line expresses red fluorescent protein and tva in Tacl-positive neurons; the fourth line targets FlpO expression to Plekhg1 expressing neurons, providing a powerful approach to modify gene expression in thalamic excitatory neurons.
C1 [Wu, Youmei; Luna, Maria Jose; Bonilla, Lauren S.; Ryba, Nicholas J. P.] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA.
   [Pickel, James M.] NIMH, NIH, Bethesda, MD 20892 USA.
RP Ryba, NJP (reprint author), Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA.
EM nick.ryba@nih.gov
OI Ryba, Nicholas/0000-0002-2060-8393
FU National Institutes of Health, National Institute of Dental and
   Craniofacial Research [ZIA-DE000561]; National Institute of Mental
   Health [ZIA-MH002901]
FX This work was supported by the Intramural program of the National
   Institutes of Health, National Institute of Dental and Craniofacial
   Research (N.J.P.R.) ZIA-DE000561 and the National Institute of Mental
   Health (J.M.P.) ZIA-MH002901. The funders had no role in the study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030
   Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186
   Harris JA, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00076
   Horii T, 2016, ENDOCR J, V63, P213, DOI 10.1507/endocrj.EJ15-0734
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Kaneko T, 2015, METHODS MOL BIOL, V1239, P307, DOI 10.1007/978-1-4939-1862-1_18
   Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398
   Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451
   Ma YW, 2016, RNA BIOL, V13, P605, DOI 10.1080/15476286.2016.1185591
   Ma YW, 2014, FEBS J, V281, P3779, DOI 10.1111/febs.12935
   Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190
   Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325
   Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410
   Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2
   Osakada F, 2013, NAT PROTOC, V8, P1583, DOI 10.1038/nprot.2013.094
   Peng YQ, 2015, NATURE, V527, P512, DOI 10.1038/nature15763
   Reardon TR, 2016, NEURON, V89, P711, DOI 10.1016/j.neuron.2016.01.004
   Sakuma Tetsushi, 2017, Methods Mol Biol, V1630, P25, DOI 10.1007/978-1-4939-7128-2_2
   Tan CL, 2016, CELL, V167, P47, DOI 10.1016/j.cell.2016.08.028
   Viswanathan S, 2015, NAT METHODS, V12, P568, DOI 10.1038/nmeth.3365
   Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999
   Wu J, 2007, CELL MOL LIFE SCI, V64, P2933, DOI 10.1007/s00018-007-7206-8
   Yang HY, 2014, BIOMED RES INT, DOI 10.1155/2014/569325
NR 27
TC 1
Z9 1
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 27
PY 2018
VL 13
IS 2
AR e0193129
DI 10.1371/journal.pone.0193129
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FX7BV
UT WOS:000426242400015
PM 29485996
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Anderson, EM
   McClelland, S
   Maksimova, E
   Strezoska, Z
   Basila, M
   Briner, AE
   Barrangou, R
   Smith, AV
AF Anderson, Emily M.
   McClelland, Shawn
   Maksimova, Elena
   Strezoska, Zaklina
   Basila, Megan
   Briner, Alexandra E.
   Barrangou, Rodolphe
   Smith, Anja van Brabant
TI Lactobacillus gasseri CRISPR-Cas9 characterization In Vitro reveals a
   flexible mode of protospacer-adjacent motif recognition
SO PLOS ONE
LA English
DT Article
ID RNA-GUIDED ENDONUCLEASE; CAS SYSTEMS; STRUCTURAL BASIS; DIVERSITY; PAM
AB While the CRISPR-Cas9 system from S. pyogenes is a powerful genome engineering tool, additional programmed nucleases would enable added flexibility in targeting space and multiplexing. Here, we characterized a CRISPR-Cas9 system from L. gasseri and found that it has modest activity in a cell-free lysate assay but no activity in mammalian cells even when altering promoter, position of tag sequences and NLS, and length of crRNA:tracrRNA. In the lysate assay we tested over 400 sequential crRNA target sequences and found that the Lga Cas9 PAM is NNGA/NDRA, different than NTAA predicted from the native bacterial host. In addition, we found multiple instances of consecutive crRNA target sites, indicating flexibility in either PAM sequence or distance from the crRNA target site. This work highlights the need for characterization of new CRISPR systems and highlights the non-triviality of porting them into eukaryotes as gene editing tools.
C1 [Anderson, Emily M.; McClelland, Shawn; Maksimova, Elena; Strezoska, Zaklina; Basila, Megan; Smith, Anja van Brabant] Dharmacon, Lafayette, CO 80026 USA.
   [Briner, Alexandra E.; Barrangou, Rodolphe] North Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC USA.
RP Smith, AV (reprint author), Dharmacon, Lafayette, CO 80026 USA.
EM anja.smith@horizondiscovery.com
RI Barrangou, Rodolphe/I-2878-2014
OI Barrangou, Rodolphe/0000-0002-0648-3504; Crawley,
   Alexandra/0000-0002-3970-9506
FU GE Healthcare Dharmacon, Inc.; North Carolina State University
FX "This work was funded by GE Healthcare Dharmacon, Inc. and internal
   funding from North Carolina State University. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579
   Anderson EM, 2015, J BIOTECHNOL, V211, P56, DOI 10.1016/j.jbiotec.2015.06.427
   Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659
   Briner A, 2014, MOL CELL IN PRESS
   Chandrasegaran S, 2016, J MOL BIOL, V428, P963, DOI 10.1016/j.jmb.2015.10.014
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096
   Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015
   Hultquist JF, 2016, CELL REP, V17, P1438, DOI 10.1016/j.celrep.2016.09.080
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Komor AC, 2017, CELL, V169, P559, DOI 10.1016/j.cell.2017.04.005
   Leenay RT, 2017, J MOL BIOL, V429, P177, DOI 10.1016/j.jmb.2016.11.024
   Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031
   Liu L, 2017, MOL CELL, V65, P310, DOI 10.1016/j.molcel.2016.11.040
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567
   Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299
   Sanozky-Dawes R, 2015, MICROBIOL-SGM, V161, P1752, DOI 10.1099/mic.0.000129
   Scaringe SA, 2001, METHODS, V23, P206, DOI 10.1006/meth.2000.1132
   Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764
   Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184
   Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008
   Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011
   Strezoska Z, 2017, J BIOTECHNOL, V251, P189, DOI 10.1016/j.jbiotec.2017.04.017
   Swarts DC, 2017, MOL CELL, V66, P221, DOI 10.1016/j.molcel.2017.03.016
   Tan J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168968
   Wang T, 2016, COLD SPRING HARBOR P, V2016
   WINCOTT F, 1995, NUCLEIC ACIDS RES, V23, P2677, DOI 10.1093/nar/23.14.2677
   Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038
NR 29
TC 0
Z9 0
U1 1
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 2
PY 2018
VL 13
IS 2
AR e0192181
DI 10.1371/journal.pone.0192181
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FU7VI
UT WOS:000424060400029
PM 29394276
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Basila, M
   Kelley, ML
   Smith, AV
AF Basila, Megan
   Kelley, Melissa L.
   Smith, Anja van Brabant
TI Minimal 2 '-O-methyl phosphorothioate linkage modification pattern of
   synthetic guide RNAs for increased stability and efficient CRISPR-Cas9
   gene editing avoiding cellular toxicity
SO PLOS ONE
LA English
DT Article
ID HUMAN T-CELLS; OLIGONUCLEOTIDE SYNTHESIS; CAS9 RIBONUCLEOPROTEINS;
   GENOME; DELIVERY; DNA; HYBRIDIZATION; ENDONUCLEASE; INTERFERENCE; CRRNA
AB Since its initial application in mammalian cells, CRISPR-Cas9 has rapidly become a preferred method for genome engineering experiments. The Cas9 nuclease is targeted to genomic DNA using guide RNAs (gRNA), either as the native dual RNA system consisting of a DNA-targeting CRISPR RNA (crRNA) and a trans-activating crRNA (tracrRNA), or as a chimeric single guide RNA (sgRNA). Entirely DNA-free CRISPR-Cas9 systems using either Cas9 protein or Cas9 mRNA and chemically synthesized gRNAs allow for transient expression of CRISPR-Cas9 components, thereby reducing the potential for off-targeting, which is a significant advantage in therapeutic applications. In addition, the use of synthetic gRNA allows for the incorporation of chemical modifications for enhanced properties including improved stability. Previous studies have demonstrated the utility of chemically modified gRNAs, but have focused on one pattern with multiple modifications in co-electroporation with Cas9 mRNA or multiple modifications and patterns with Cas9 plasmid lipid co-transfections. Here we present gene editing results using a series of chemically modified synthetic sgRNA molecules and chemically modified crRNA: tracrRNA molecules in both electroporation and lipid transfection assessing indel formation and/ or phenotypic gene knockout. We show that while modifications are required for co-electroporation with Cas9 mRNA, some modification patterns of the gRNA are toxic to cells compared to the unmodified gRNA and most modification patterns do not significantly improve gene editing efficiency. We also present modification patterns of the gRNA that can modestly improve Cas9 gene editing efficiency when co-transfected with Cas9 mRNA or Cas9 protein (> 1.5-fold difference). These results indicate that for certain applications, including those relevant to primary cells, the incorporation of some, but not all chemical modification patterns on synthetic crRNA: tracrRNA or sgRNA can be beneficial to CRISPR-Cas9 gene editing.
C1 [Basila, Megan; Kelley, Melissa L.; Smith, Anja van Brabant] Dharmacon, Lafayette, CO 80026 USA.
RP Smith, AV (reprint author), Dharmacon, Lafayette, CO 80026 USA.
EM anja.smith@horizondiscovery.com
RI LI, JIE/I-5695-2015
OI LI, JIE/0000-0003-0189-2787
FU GE Healthcare Dharmacon, Inc.
FX This work was funded by GE Healthcare Dharmacon, Inc. The funder
   provided support in the form of salaries for authors [MB, MLK, AvBS],
   but did not have any additional role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. The specific roles of these authors are articulated in the
   'author contributions' section.
CR Allerson CR, 2005, J MED CHEM, V48, P901, DOI 10.1021/jm049167j
   Anderson EM, 2015, J BIOTECHNOL, V211, P56, DOI 10.1016/j.jbiotec.2015.06.427
   Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507
   Choung S, 2006, BIOCHEM BIOPH RES CO, V342, P919, DOI 10.1016/j.bbrc.2006.02.049
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   CUMMINS LL, 1995, NUCLEIC ACIDS RES, V23, P2019, DOI 10.1093/nar/23.11.2019
   Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538
   Deng WL, 2015, P NATL ACAD SCI USA, V112, P11870, DOI 10.1073/pnas.1515692112
   DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336
   FISHER TL, 1993, NUCLEIC ACIDS RES, V21, P3857, DOI 10.1093/nar/21.16.3857
   Ge Q, 2010, RNA, V16, P118, DOI 10.1261/rna.1901810
   Gori JL, 2015, HUM GENE THER, V26, P443, DOI 10.1089/hum.2015.074
   Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290
   Hough SR, 2003, NAT BIOTECHNOL, V21, P731, DOI 10.1038/nbt0703-731b
   Hultquist JF, 2016, CELL REP, V17, P1438, DOI 10.1016/j.celrep.2016.09.080
   INOUE H, 1987, NUCLEIC ACIDS RES, V15, P6131, DOI 10.1093/nar/15.15.6131
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203
   Kelley ML, 2016, J BIOTECHNOL, V233, P74, DOI 10.1016/j.jbiotec.2016.06.011
   Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113
   Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132
   Li L, 2015, HUM GENE THER, V26, P452, DOI 10.1089/hum.2015.069
   Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024
   Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001
   Rahdar M, 2015, P NATL ACAD SCI USA, V112, pE7110, DOI 10.1073/pnas.1520883112
   Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299
   Robbins M, 2007, MOL THER, V15, P1663, DOI 10.1038/sj.mt.6300240
   Scaringe SA, 2001, METHODS, V23, P206, DOI 10.1006/meth.2000.1132
   Scaringe SA, 1998, J AM CHEM SOC, V120, P11820, DOI 10.1021/ja980730v
   Scaringe SA, 2000, METHOD ENZYMOL, V317, P3
   Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112
   Strezoska Z, 2017, J BIOTECHNOL, V251, P189, DOI 10.1016/j.jbiotec.2017.04.017
   Tan J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168968
   Wang Z, 2004, GENE THER, V11, P711, DOI 10.1038/sj.gt.3302213
   Yang L, 2014, METHOD MOL BIOL, V1114, P291
   Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038
NR 39
TC 3
Z9 3
U1 2
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 27
PY 2017
VL 12
IS 11
AR e0188593
DI 10.1371/journal.pone.0188593
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FN8QZ
UT WOS:000416291900104
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Slotta, C
   Schluter, T
   Ruiz-Perera, LM
   Kadhim, HM
   Tertel, T
   Henkel, E
   Hubner, W
   Greiner, JFW
   Huser, T
   Kaltschmidt, B
   Kaltschmidt, C
AF Slotta, Carsten
   Schlueter, Thomas
   Ruiz-Perera, Lucia M.
   Kadhim, Hussamadin M.
   Tertel, Tobias
   Henkel, Elena
   Huebner, Wolfgang
   Greiner, Johannes F. W.
   Huser, Thomas
   Kaltschmidt, Barbara
   Kaltschmidt, Christian
TI CRISPR/Cas9-mediated knockout of c-REL in HeLa cells results in profound
   defects of the cell cycle
SO PLOS ONE
LA English
DT Article
ID NF-KAPPA-B; CERVICAL-CANCER CELLS; BREAST-CANCER; HUMAN-PAPILLOMAVIRUS;
   TRANSCRIPTION FACTOR; HUMAN GENOME; LUNG-CANCER; V-REL; APOPTOSIS;
   EXPRESSION
AB Cervical cancer is the fourth common cancer in women resulting worldwide in 266,000 deaths per year. Belonging to the carcinomas, new insights into cervical cancer biology may also have great implications for finding new treatment strategies for other kinds of epithelial cancers. Although the transcription factor NF-kappa B is known as a key player in tumor formation, the relevance of its particular subunits is still underestimated. Here, we applied CRISPR/Cas9n-mediated genome editing to successfully knockout the NF-kappa B subunit c-REL in HeLa Kyoto cells as a model system for cervical cancers. We successfully generated a homozygous deletion in the c-REL gene, which we validated using sequencing, qPCR, immunocytochemistry, western blot analysis, EMSA and analysis of off-target effects. On the functional level, we observed the deletion of c-REL to result in a significantly decreased cell proliferation in comparison to wildtype (wt) without affecting apoptosis. The impaired proliferative behavior of c-REL-/- cells was accompanied by a strongly decreased amount of the H2B protein as well as a significant delay in the prometaphase of mitosis compared to c-REL+/+ HeLa Kyoto cells. c-REL-/- cells further showed significantly decreased expression levels of c-REL target genes in comparison to wt. In accordance to our proliferation data, we observed the c-REL knockout to result in a significantly increased resistance against the chemotherapeutic agents 5-Fluoro-2'-deoxyuridine (5-FUDR) and cisplatin. In summary, our findings emphasize the importance of c-REL signaling in a cellular model of cervical cancer with direct clinical implications for the development of new treatment strategies.
C1 [Slotta, Carsten; Schlueter, Thomas; Kadhim, Hussamadin M.; Tertel, Tobias; Henkel, Elena; Greiner, Johannes F. W.; Kaltschmidt, Barbara; Kaltschmidt, Christian] Univ Bielefeld, Dept Cell Biol, Bielefeld, Germany.
   [Ruiz-Perera, Lucia M.; Kaltschmidt, Barbara] Univ Bielefeld, AG Mol Neurobiol, Bielefeld, Germany.
   [Huebner, Wolfgang; Huser, Thomas] Univ Bielefeld, Biomol Photon, Bielefeld, Germany.
RP Kaltschmidt, C (reprint author), Univ Bielefeld, Dept Cell Biol, Bielefeld, Germany.
EM c.kaltschmidt@uni-bielefeld.de
RI Huser, Thomas/K-7291-2019
OI Huser, Thomas/0000-0003-2348-7416; Greiner, Johannes/0000-0002-0524-662X
CR Adli M, 2006, J BIOL CHEM, P281
   [Anonymous], 2005, CELL INT, V5, P10
   Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060
   BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N
   Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200
   Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   De Siervi A, 2009, CELL CYCLE, V8, P2093, DOI 10.4161/cc.8.13.8926
   Eddy SF, 2005, CANCER RES, V65, P11375, DOI 10.1158/0008-5472.CAN-05-1602
   Forbes SA, 2014, CANC
   Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075
   Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299
   Garland SM, 2002, PATHOLOGY, V34, P213, DOI [10.1080/00313020212469, 10.1080/00313020220131255]
   Gilmore T. D, NF KB TARGET GENES
   Gilmore TD, 1999, ONCOGENE, V18, P6925, DOI 10.1038/sj.onc.1203222
   Gilmore TD, 2004, ONCOGENE, V23, P2275, DOI 10.1038/sj.onc.1207410
   Gilmore TD, 2001, ONCOGENE, V20, P7098, DOI 10.1038/sj.onc.1204898
   Grey ST, 1999, J EXP MED, V190, P1135, DOI 10.1084/jem.190.8.1135
   Grossmann M, 2000, EMBO J, V19, P6351, DOI 10.1093/emboj/19.23.6351
   Grumont R, 2004, IMMUNITY, V21, P19, DOI 10.1016/j.immuni.2004.06.004
   Grumont RJ, 1998, J EXP MED, V187, P663, DOI 10.1084/jem.187.5.663
   Hamada K, 1996, CANCER RES, V56, P3047
   Harris J, 2006, J IMMUNOL, V177, P2527, DOI 10.4049/jimmunol.177.4.2527
   Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555
   Houldsworth J, 2004, BLOOD, V103, P1862, DOI 10.1182/blood-2003-04-1359
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Kaltschmidt B, 1999, ONCOGENE, V18, P3213, DOI 10.1038/sj.onc.1202657
   Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271
   Kang YJ, 2015, CANCER EPIDEMIOL, V39, P600, DOI 10.1016/j.canep.2015.04.009
   Krappmann D, 1999, ONCOGENE, V18, P943, DOI 10.1038/sj.onc.1202351
   Li QT, 2005, TRENDS IMMUNOL, V26, P318, DOI 10.1016/j.it.2005.04.003
   Lorenz VN, 2014, J INVEST DERMATOL, V134, P415, DOI 10.1038/jid.2013.315
   Lorusso D, 2014, GYNECOL ONCOL, V133, P117, DOI 10.1016/j.ygyno.2014.01.042
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802
   Nair A, 2003, ONCOGENE, V22, P50, DOI 10.1038/sj.onc.1206043
   Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869
   Nishiyama M, 1999, CLIN CANCER RES, V5, P2620
   Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838
   Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083
   Peters GJ, 2002, BBA-MOL BASIS DIS, V1587, P194, DOI 10.1016/S0925-4439(02)00082-0
   Priyadarsini RV, 2010, EUR J PHARMACOL, V649, P84, DOI 10.1016/j.ejphar.2010.09.020
   Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021
   Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914
   Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070
   Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400
   Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(07)61416-0
   SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X
   SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6
   Shehata M, 2005, CELL BIOL INT, V29, P429, DOI 10.1016/j.cellbi.2004.12.014
   Shehata M, 2004, CELL BIOL INT, V28, P895, DOI 10.1016/j.cellbi.2004.09.002
   Soucek L, 2013, GENE DEV, V27, P504, DOI 10.1101/gad.205542.112
   Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848
   Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633
   Stewart B. W. K. P., 2014, WORLD CANC REPORT
   Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x
   Tian WZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005028
   Tokunaga S, 2014, ANAL BIOCHEM, V465, P70, DOI 10.1016/j.ab.2014.06.020
   Wang CY, 1999, NAT MED, V5, P412
   Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691
   WILHELMSEN KC, 1984, J VIROL, V52, P172
   Xia YF, 2014, CANCER IMMUNOL RES, V2, P823, DOI 10.1158/2326-6066.CIR-14-0112
   Yang LN, 2015, CANCER LETT, V357, P520, DOI 10.1016/j.canlet.2014.12.003
   Zhao Y, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035001
NR 64
TC 5
Z9 5
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 2
PY 2017
VL 12
IS 8
AR e0182373
DI 10.1371/journal.pone.0182373
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FC3VT
UT WOS:000406768200073
PM 28767691
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Javidi-Parsijani, P
   Niu, GG
   Davis, M
   Lu, P
   Atala, A
   Lu, BS
AF Javidi-Parsijani, Parisa
   Niu, Guoguang
   Davis, Meghan
   Lu, Pin
   Atala, Anthony
   Lu, Baisong
TI No evidence of genome editing activity from Natronobacterium gregoryi
   Argonaute (NgAgo) in human cells
SO PLOS ONE
LA English
DT Article
ID DNA-BINDING SPECIFICITY; INTRACELLULAR TRAFFICKING; MUSCLE; MODEL
AB The argonaute protein from the thermophilic bacterium Thermus thermophilus shows DNA-guided DNA interfering activity at high temperatures, complicating its application in mammalian cells. A recent work reported that the argonaute protein from Natronobacterium gregoryi (NgAgo) had DNA-guided genome editing activity in mammalian cells. We compared the genome editing activities of NgAgo and Staphylococcus aureus Cas9 (SaCas9) in human HEK293T cells side by side. EGFP reporter assays and DNA sequencing consistently revealed high genome editing activity from SaCas9. However, these assays did not demonstrate genome editing activity by NgAgo. We confirmed that the conditions allowed simultaneous transfection of the NgAgo expressing plasmid DNA and DNA guides, as well as heterologous expression of NgAgo in the HEK293T cells. Our data show that NgAgo is not a robust genome editing tool, although it may have such activity under other conditions.
C1 [Javidi-Parsijani, Parisa; Niu, Guoguang; Davis, Meghan; Lu, Pin; Atala, Anthony; Lu, Baisong] Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA.
RP Lu, BS (reprint author), Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA.
EM blu@wakehealth.edu
RI Lu, Baisong/B-5837-2013
OI Lu, Baisong/0000-0001-9240-558X
FU NCATS NIH HHS [UL1 TR001420]
CR Bhattacharyya D, 2010, METHODS MOL BIOL, V619, P403, DOI 10.1007/978-1-60327-412-8_24
   Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512
   Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811
   Burgess S, 2016, PROTEIN CELL, V7, P913, DOI 10.1007/s13238-016-0343-9
   Cardarelli F, 2016, SCI REP-UK, V6, DOI 10.1038/srep25879
   Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Cornu TI, 2008, MOL THER, V16, P352, DOI 10.1038/sj.mt.6300357
   DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379
   Elouahabi A, 2005, MOL THER, V11, P336, DOI 10.1016/j.ymthe.2004.12.006
   Gao F, 2016, NAT BIOTECHNOL, V34, P768, DOI 10.1038/nbt.3547
   Green M. R., 2012, MOLECULAR CLONING A
   Hansel-Hertsch R, 2016, NAT GENET, V48, P1267, DOI 10.1038/ng.3662
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156
   Lee SH, 2017, NAT BIOTECHNOL, V35, P17, DOI 10.1038/nbt.3753
   Li X, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136630
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755
   Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817
   Naujok Ortwin, 2016, Methods Mol Biol, V1341, P67, DOI 10.1007/7651_2015_221
   Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143
   Qi JL, 2016, CELL RES, V26, P1349, DOI 10.1038/cr.2016.134
   Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299
   Swarts DC, 2015, NUCLEIC ACIDS RES, V43, P5120, DOI 10.1093/nar/gkv415
   Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971
   Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177
   Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662
   Ye S, 2017, BIORXIV, DOI DOI 10.1101/101923
   Yonezawa M, 1996, INT J CANCER, V66, P347
   Zander A, 2014, RNA BIOL, V11, P45, DOI 10.4161/rna.27446
NR 32
TC 8
Z9 9
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 11
PY 2017
VL 12
IS 5
AR e0177444
DI 10.1371/journal.pone.0177444
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EU8UP
UT WOS:000401314300110
PM 28494027
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Gerl, MJ
   Bittl, V
   Kirchner, S
   Sachsenheimer, T
   Brunner, HL
   Luchtenborg, C
   Ozbalci, C
   Wiedemann, H
   Wegehingel, S
   Nickel, W
   Haberkant, P
   Schultz, C
   Kruger, M
   Brugger, B
AF Gerl, Mathias J.
   Bittl, Verena
   Kirchner, Susanne
   Sachsenheimer, Timo
   Brunner, Hanna L.
   Luechtenborg, Christian
   Oezbalci, Cagakan
   Wiedemann, Hannah
   Wegehingel, Sabine
   Nickel, Walter
   Haberkant, Per
   Schultz, Carsten
   Krueger, Marcus
   Bruegger, Britta
TI Sphingosine-1-Phosphate Lyase Deficient Cells as a Tool to Study Protein
   Lipid Interactions
SO PLOS ONE
LA English
DT Article
ID SPHINGOSINE 1-PHOSPHATE; CLICK CHEMISTRY; SPHINGOLIPID INTERACTIONS;
   QUANTITATIVE-ANALYSIS; MEMBRANE; CRISPR-CAS9; METABOLISM; LIVER;
   DEHYDROGENASE; PURIFICATION
AB Cell membranes contain hundreds to thousands of individual lipid species that are of structural importance but also specifically interact with proteins. Due to their highly controlled synthesis and role in signaling events sphingolipids are an intensely studied class of lipids. In order to investigate their metabolism and to study proteins interacting with sphingolipids, metabolic labeling based on photoactivatable sphingoid bases is the most straightforward approach. In order to monitor protein-lipid-crosslink products, sphingosine derivatives containing a reporter moiety, such as a radiolabel or a clickable group, are used. In normal cells, degradation of sphingoid bases via action of the checkpoint enzyme sphingosine-1-phosphate lyase occurs at position C2-C3 of the sphingoid base and channels the resulting hexadecenal into the glycerolipid biosynthesis pathway. In case the functionalized sphingosine looses the reporter moiety during its degradation, specificity towards sphingolipid labeling is maintained. In case degradation of a sphingosine derivative does not remove either the photoactivatable or reporter group from the resulting hexadecenal, specificity towards sphingolipid labeling can be achieved by blocking sphingosine-1-phosphate lyase activity and thus preventing sphingosine derivatives to be channeled into the sphingolipid-to-glycerolipid metabolic pathway. Here we report an approach using clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated nuclease Cas9 to create a sphingosine-1-phosphate lyase (SGPL1) HeLa knockout cell line to disrupt the sphingolipid-to-glycerolipid metabolic pathway. We found that the lipid and protein compositions as well as sphingolipid metabolism of SGPL1 knock-out HeLa cells only show little adaptations, which validates these cells as model systems to study transient protein-sphingolipid interactions.
C1 [Gerl, Mathias J.; Bittl, Verena; Kirchner, Susanne; Sachsenheimer, Timo; Brunner, Hanna L.; Luechtenborg, Christian; Oezbalci, Cagakan; Wiedemann, Hannah; Wegehingel, Sabine; Nickel, Walter; Bruegger, Britta] Heidelberg Univ, Biochem Ctr, Heidelberg, Germany.
   [Haberkant, Per; Schultz, Carsten] European Mol Biol Lab, Heidelberg, Germany.
   [Krueger, Marcus] CECAD, Cologne, Germany.
   [Gerl, Mathias J.] Lipotype GmbH, Tatzberg 47, D-01307 Dresden, Germany.
RP Gerl, MJ; Brugger, B (reprint author), Heidelberg Univ, Biochem Ctr, Heidelberg, Germany.; Gerl, MJ (reprint author), Lipotype GmbH, Tatzberg 47, D-01307 Dresden, Germany.
EM Mathias.Gerl@bzh.uni-heidelberg.de;
   britta.bruegger@bzh.uni-heidelberg.de
OI Schultz, Carsten/0000-0002-5824-2171; Gerl, Mathias/0000-0002-8074-7221
FU Deutsche Forschungsgemeinschaft [GE 2516/1-1, TRR 83]; CellNetworks
   Cluster of Excellence [EXC81]
FX MJG was funded by the Deutsche Forschungsgemeinschaft: GE 2516/1-1
   (www.dfg.de/en/). BB is supported by a grant from the Deutsche
   Forschungsgemeinschaft within TRR 83 (http://www.trr83.de) and is
   investigator of the CellNetworks Cluster of Excellence: EXC81
   (http://www.cellnetworks.uni-hd.de).
CR Aguilar Ana, 2012, Adv Biol Regul, V52, P17
   Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489
   Bibikova M, 2002, GENETICS, V161, P1169
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Brugger B, 2000, J CELL BIOL, V151, P507, DOI 10.1083/jcb.151.3.507
   Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103
   Carlson M, 2015, TXDB HSAPIENS UCSC H
   Colie S, 2009, CANCER RES, V69, P9346, DOI 10.1158/0008-5472.CAN-09-2198
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742
   Contreras FX, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004705
   Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0
   Damen CWN, 2014, J LIPID RES, V55, P1772, DOI 10.1194/jlr.D047795
   Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200
   Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200
   Flores-Martin J, 2013, INT J MOL SCI, V14, P6170, DOI 10.3390/ijms14036170
   Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006
   Gerl MJ, 2012, J CELL BIOL, V196, P213, DOI 10.1083/jcb.201108175
   Haberkant P, 2008, J LIPID RES, V49, P251, DOI 10.1194/jlr.D700023-JLR200
   Haberkant P, 2016, ACS CHEM BIOL, V11, P222, DOI 10.1021/acschembio.5b00810
   Haberkant P, 2014, BBA-MOL CELL BIOL L, V1841, P1022, DOI 10.1016/j.bbalip.2014.01.003
   Haberkant P, 2013, ANGEW CHEM INT EDIT, V52, P4033, DOI 10.1002/anie.201210178
   Hagen N, 2011, CELL DEATH DIFFER, V18, P1356, DOI 10.1038/cdd.2011.7
   Hagen N, 2009, J BIOL CHEM, V284, P11346, DOI 10.1074/jbc.M807336200
   Hagen-Euteneuer N, 2012, J BIOL CHEM, V287, P9128, DOI 10.1074/jbc.M111.302380
   Hahne F., 2013, R PACKAGE VERSION, V1, P4
   Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709
   Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329
   Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359
   Heal WP, 2012, NAT PROTOC, V7, P105, DOI 10.1038/nprot.2011.425
   Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812
   Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323
   Hla T, 2011, NEUROLOGY, V76, pS3, DOI 10.1212/WNL.0b013e31820d5ec1
   Horibata Y, 2010, J BIOL CHEM, V285, P7358, DOI 10.1074/jbc.M109.056960
   Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010
   Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/NMETH.2368, 10.1038/nmeth.2368]
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Kelson TL, 1997, BBA-GEN SUBJECTS, V1335, P99, DOI 10.1016/S0304-4165(96)00126-2
   Kim R, 2013, J LIPID RES, V54, P265, DOI 10.1194/jlr.D029207
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X
   Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200
   Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Nakahara K, 2012, MOL CELL, V46, P461, DOI 10.1016/j.molcel.2012.04.033
   Narayanaswamy P, 2014, ANAL CHEM, V86, P3043, DOI 10.1021/ac4039652
   Ozbalci C, 2013, METHODS MOL BIOL, V1033, P3, DOI 10.1007/978-1-62703-487-6_1
   PALTAUF F, 1994, PROG LIPID RES, V33, P239, DOI 10.1016/0163-7827(94)90028-0
   R Development Core Team T, 2011, R LANG ENV STAT COMP
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Rohlfing A, 2007, ANAL CHEM, V79, P5793, DOI 10.1021/ac070633x
   Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087
   Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]
   Shieh P, 2012, J AM CHEM SOC, V134, P17428, DOI 10.1021/ja308203h
   Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977
   STOFFEL W, 1967, H-S Z PHYSIOL CHEM, V348, P941
   Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113
   Team T, 2015, SGENOME HSAPIENS UCS
   Thiele C, 2012, ACS CHEM BIOL, V7, P2004, DOI 10.1021/cb300414v
   Turinetto V, 2015, NUCLEIC ACIDS RES, V43, P2489, DOI 10.1093/nar/gkv061
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330
   Van Veldhoven PP, 2000, BBA-MOL CELL BIOL L, V1487, P128, DOI 10.1016/S1388-1981(00)00079-2
   Wakashima T, 2014, J BIOL CHEM, V289, P24736, DOI 10.1074/jbc.M114.571869
   Wenk MR, 2010, CELL, V143, P888, DOI 10.1016/j.cell.2010.11.033
   WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   Yamaji T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088124
   Zacherl S, 2015, J BIOL CHEM, V290, P3654, DOI 10.1074/jbc.M114.590067
NR 70
TC 12
Z9 12
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 21
PY 2016
VL 11
IS 4
AR e0153009
DI 10.1371/journal.pone.0153009
PG 25
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DK4OR
UT WOS:000374898500021
PM 27100999
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Wallen, MC
   Gaj, T
   Barbas, CF
AF Wallen, Mark C.
   Gaj, Thomas
   Barbas, Carlos F., III
TI Redesigning Recombinase Specificity for Safe Harbor Sites in the Human
   Genome
SO PLOS ONE
LA English
DT Article
ID ZINC-FINGER NUCLEASES; DNA-SEQUENCE SPECIFICITY; GAMMA-DELTA-RESOLVASE;
   HUMAN-CELLS; DIRECTED EVOLUTION; SERINE RECOMBINASE;
   STAPHYLOCOCCUS-AUREUS; CHIMERIC NUCLEASES; MAMMALIAN GENOMES;
   CRYSTAL-STRUCTURE
AB Site-specific recombinases (SSRs) are valuable tools for genetic engineering due to their ability to manipulate DNA in a highly specific manner. Engineered zinc-finger and TAL effector recombinases, in particular, are two classes of SSRs composed of custom-designed DNA-binding domains fused to a catalytic domain derived from the resolvase/invertase family of serine recombinases. While TAL effector and zinc-finger proteins can be assembled to recognize a wide range of possible DNA sequences, recombinase catalytic specificity has been constrained by inherent base requirements present within each enzyme. In order to further expand the targeted recombinase repertoire, we used a genetic screen to isolate enhanced mutants of the Bin and Tn21 recombinases that recognize target sites outside the scope of other engineered recombinases. We determined the specific base requirements for recombination by these enzymes and demonstrate their potential for genome engineering by selecting for variants capable of specifically recombining target sites present in the human CCR5 gene and the AAVS1 safe harbor locus. Taken together, these findings demonstrate that complementing functional characterization with protein engineering is a potentially powerful approach for generating recombinases with expanded targeting capabilities.
C1 [Wallen, Mark C.; Gaj, Thomas; Barbas, Carlos F., III] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.
   [Wallen, Mark C.; Gaj, Thomas; Barbas, Carlos F., III] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.
   [Wallen, Mark C.; Gaj, Thomas; Barbas, Carlos F., III] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA.
RP Wallen, MC (reprint author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.
EM mcwallen@scripps.edu
FU National Institutes of Health [DP1 CA174426]; Skaggs Institute for
   Chemical Biology
FX This work was supported by National Institutes of Health (Pioneer Award
   DP1 CA174426 to C.F.B.) and The Skaggs Institute for Chemical Biology.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Akopian A, 2003, P NATL ACAD SCI USA, V100, P8688, DOI 10.1073/pnas.1533177100
   Arnold PH, 1999, EMBO J, V18, P1407, DOI 10.1093/emboj/18.5.1407
   Bhakta MS, 2013, GENOME RES, V23, P530, DOI 10.1101/gr.143693.112
   Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001
   Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512
   Bibikova M, 2002, GENETICS, V161, P1169
   Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811
   Bolusani S, 2006, NUCLEIC ACIDS RES, V34, P5259, DOI 10.1093/nar/gkl548
   Buchholz F, 2001, NAT BIOTECHNOL, V19, P1047, DOI 10.1038/nbt1101-1047
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110
   Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623
   Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948
   Gaj T, 2014, METHOD ENZYMOL, V546, P79, DOI 10.1016/B978-0-12-801185-0.00004-0
   Gaj T, 2014, J AM CHEM SOC, V136, P5047, DOI 10.1021/ja4130059
   Gaj T, 2014, BIOTECHNOL BIOENG, V111, P1, DOI 10.1002/bit.25096
   Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004
   Gaj T, 2013, NUCLEIC ACIDS RES, V41, P3937, DOI 10.1093/nar/gkt071
   Gaj T, 2011, P NATL ACAD SCI USA, V108, P498, DOI 10.1073/pnas.1014214108
   Gersbach CA, 2014, ACCOUNTS CHEM RES, V47, P2309, DOI 10.1021/ar500039w
   Gersbach CA, 2010, NUCLEIC ACIDS RES, V38, P4198, DOI [10.1093/nar/gka125, 10.1093/nar/gkq125]
   GLASGOW AC, 1989, J BIOL CHEM, V264, P10072
   Gordley RM, 2007, J MOL BIOL, V367, P802, DOI 10.1016/j.jmb.2007.01.017
   Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908
   Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   KAHMANN R, 1985, CELL, V41, P771, DOI 10.1016/S0092-8674(85)80058-1
   Keenholtz RA, 2011, STRUCTURE, V19, P799, DOI 10.1016/j.str.2011.03.017
   Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517
   KLIPPEL A, 1988, EMBO J, V7, P3983, DOI 10.1002/j.1460-2075.1988.tb03286.x
   Kolb AF, 2005, TRENDS BIOTECHNOL, V23, P399, DOI 10.1016/j.tibech.2005.06.005
   KRASNOW MA, 1983, CELL, V32, P1313, DOI 10.1016/0092-8674(83)90312-4
   Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209
   Mercer AC, 2012, NUCLEIC ACIDS RES, V40, P11163, DOI 10.1093/nar/gks875
   Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755
   Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817
   NEWMAN BJ, 1984, CELL, V38, P463, DOI 10.1016/0092-8674(84)90501-4
   Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395
   Proudfoot C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019537
   Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170
   Ritacco CJ, 2013, NUCLEIC ACIDS RES, V41, P2673, DOI 10.1093/nar/gks1303
   ROGOWSKY P, 1985, EMBO J, V4, P2135, DOI 10.1002/j.1460-2075.1985.tb03904.x
   ROJO F, 1995, NUCLEIC ACIDS RES, V23, P3181, DOI 10.1093/nar/23.16.3181
   Rowland SJ, 2009, MOL MICROBIOL, V74, P282, DOI 10.1111/j.1365-2958.2009.06756.x
   ROWLAND SJ, 1990, MOL MICROBIOL, V4, P961, DOI 10.1111/j.1365-2958.1990.tb00669.x
   Rowland SJ, 2002, MOL MICROBIOL, V44, P607, DOI 10.1046/j.1365-2958.2002.02897.x
   Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179
   Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542
   Santoro SW, 2002, P NATL ACAD SCI USA, V99, P4185, DOI 10.1073/pnas.022039799
   Sarkar I, 2007, SCIENCE, V316, P1912, DOI 10.1126/science.1141453
   Schneider F, 2000, J MOL BIOL, V295, P767, DOI 10.1006/jmbi.1999.3412
   Segal DJ, 1999, P NATL ACAD SCI USA, V96, P2758, DOI 10.1073/pnas.96.6.2758
   Segal DJ, 2004, J BIOL CHEM, V279, P14509, DOI 10.1074/jbc.M400349200
   Sirk SJ, 2014, NUCLEIC ACIDS RES, V42, P4755, DOI 10.1093/nar/gkt1389
   Smith MCM, 2002, MOL MICROBIOL, V44, P299, DOI 10.1046/j.1365-2958.2002.02891.x
   Sorrell DA, 2005, BIOTECHNOL ADV, V23, P431, DOI 10.1016/j.biotechadv.2005.03.003
   Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317
   Thyagarajan B, 2000, GENE, V244, P47, DOI 10.1016/S0378-1119(00)00008-1
   Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908
   Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556
   Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842
   WELLS RG, 1984, J MOL BIOL, V179, P667, DOI 10.1016/0022-2836(84)90161-X
   YANG W, 1995, CELL, V82, P193, DOI 10.1016/0092-8674(95)90307-0
NR 67
TC 7
Z9 7
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 28
PY 2015
VL 10
IS 9
AR e0139123
DI 10.1371/journal.pone.0139123
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CS6EO
UT WOS:000362170700044
PM 26414179
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Aouida, M
   Eid, A
   Ali, Z
   Cradick, T
   Lee, C
   Deshmukh, H
   Atef, A
   AbuSamra, D
   Gadhoum, SZ
   Merzaban, J
   Bao, G
   Mahfouz, M
AF Aouida, Mustapha
   Eid, Ayman
   Ali, Zahir
   Cradick, Thomas
   Lee, Ciaran
   Deshmukh, Harshavardhan
   Atef, Ahmed
   AbuSamra, Dina
   Gadhoum, Samah Zeineb
   Merzaban, Jasmeen
   Bao, Gang
   Mahfouz, Magdy
TI Efficient fdCas9 Synthetic Endonuclease with Improved Specificity for
   Precise Genome Engineering
SO PLOS ONE
LA English
DT Article
ID NUCLEASE-INDUCED MUTATIONS; DNA-BINDING SPECIFICITY; DOUBLE-STRAND
   BREAKS; OFF-TARGET ACTIVITY; CRISPR-CAS SYSTEMS; TAL EFFECTORS;
   SACCHAROMYCES-CEREVISIAE; SURROGATE REPORTERS; GENE MODIFICATION;
   HUMAN-CELLS
AB The Cas9 endonuclease is used for genome editing applications in diverse eukaryotic species. A high frequency of off-target activity has been reported in many cell types, limiting its applications to genome engineering, especially in genomic medicine. Here, we generated a synthetic chimeric protein between the catalytic domain of the FokI endonuclease and the catalytically inactive Cas9 protein (fdCas9). A pair of guide RNAs (gRNAs) that bind to sense and antisense strands with a defined spacer sequence range can be used to form a catalytically active dimeric fdCas9 protein and generate double-strand breaks (DSBs) within the spacer sequence. Our data demonstrate an improved catalytic activity of the fdCas9 endonuclease, with a spacer range of 15-39 nucleotides, on surrogate reporters and genomic targets. Furthermore, we observed no detectable fdCas9 activity at known Cas9 off-target sites. Taken together, our data suggest that the fdCas9 endonuclease variant is a superior platform for genome editing applications in eukaryotic systems including mammalian cells.
C1 [Aouida, Mustapha; Eid, Ayman; Ali, Zahir; Atef, Ahmed; Mahfouz, Magdy] 4700 King Abdullah Univ Sci & Technol, Lab Genome Engn, Div Biol Sci, Thuwal 239556900, Saudi Arabia.
   [Aouida, Mustapha; Eid, Ayman; Ali, Zahir; Atef, Ahmed; Mahfouz, Magdy] 4700 King Abdullah Univ Sci & Technol, Ctr Desert Agr, Thuwal 239556900, Saudi Arabia.
   [Cradick, Thomas; Lee, Ciaran; Deshmukh, Harshavardhan; Bao, Gang] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Cradick, Thomas; Lee, Ciaran; Deshmukh, Harshavardhan; Bao, Gang] Emory Univ, Atlanta, GA 30332 USA.
   [AbuSamra, Dina; Gadhoum, Samah Zeineb; Merzaban, Jasmeen] King Abdullah Univ Sci & Technol, Lab Cell Signaling & Migrat, Div Biol & Environm Sci & Engn, Thuwal 23955, Saudi Arabia.
RP Mahfouz, M (reprint author), 4700 King Abdullah Univ Sci & Technol, Lab Genome Engn, Div Biol Sci, Thuwal 239556900, Saudi Arabia.
EM Magdy.mahfouz@kaust.edu.sa
RI atef, ahmed/B-7842-2013; Merzaban, Jasmeen/V-3147-2018; Eid, Ayman
   Yehia/K-8509-2019; MAHFOUZ, MAGDY/O-1550-2016
OI Merzaban, Jasmeen/0000-0002-7276-2907; Eid, Ayman
   Yehia/0000-0002-9120-9680; Aouida, Mustapha/0000-0001-7945-5320; Lee,
   Ciaran/0000-0002-0789-9149; Cradick, Thomas/0000-0002-8489-8318; Ali,
   Zahir/0000-0002-7814-8908; Atef, Ahmed/0000-0001-7530-2060; Mahfouz,
   Magdy M/0000-0002-0616-6365
FU King Abdullah University of Science and Technology
FX King Abdullah University of Science and Technology funded this study.
CR Andreas S, 2002, NUCLEIC ACIDS RES, V30, P2299, DOI 10.1093/nar/30.11.2299
   Aouida M, 2015, J BIOSCI BIOENG, V120, P364, DOI 10.1016/j.jbiosc.2015.02.017
   Aouida M, 2014, CURR GENET, V60, P61, DOI 10.1007/s00294-013-0412-z
   Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140
   Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020
   Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811
   Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001
   Chen HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099314
   Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113
   Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507
   Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714
   Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886
   Deng D, 2012, CELL RES, V22, P1502, DOI 10.1038/cr.2012.127
   DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135
   Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096
   Fine EJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1326
   Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532
   Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808
   Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909
   Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060
   Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15
   Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647
   Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939
   Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508
   Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]
   Kim YH, 2014, METHODS, V69, P108, DOI 10.1016/j.ymeth.2014.04.012
   Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916
   Li LX, 2013, MOL PLANT, V6, P1318, DOI 10.1093/mp/sst006
   Li LX, 2012, PLANT MOL BIOL, V78, P407, DOI 10.1007/s11103-012-9875-4
   Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402
   Mahfouz MM, 2014, PLANT BIOTECHNOL J, V12, P1006, DOI 10.1111/pbi.12256
   Mahfouz Magdy M, 2011, GM Crops, V2, P99, DOI 10.4161/gmcr.2.2.17254
   Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817
   Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673
   Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022
   Ramakrishna S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4378
   Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374
   Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021
   Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170
   Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]
   Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908
   Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112
   Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775
NR 50
TC 20
Z9 21
U1 1
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 30
PY 2015
VL 10
IS 7
AR e0133373
DI 10.1371/journal.pone.0133373
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO0JT
UT WOS:000358837700019
PM 26225561
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Nodvig, CS
   Nielsen, JB
   Kogle, ME
   Mortensen, UH
AF Nodvig, Christina S.
   Nielsen, Jakob B.
   Kogle, Martin E.
   Mortensen, Uffe H.
TI A CRISPR-Cas9 System for Genetic Engineering of Filamentous Fungi
SO PLOS ONE
LA English
DT Article
ID ASPERGILLUS-NIDULANS; SACCHAROMYCES-CEREVISIAE; CAS SYSTEMS; GUIDE RNAS;
   SPECIFICITY; TRANSFORMATION; ENDONUCLEASE; CRISPR/CAS9; EXPRESSION;
   EFFECTORS
AB The number of fully sequenced fungal genomes is rapidly increasing. Since genetic tools are poorly developed for most filamentous fungi, it is currently difficult to employ genetic engineering for understanding the biology of these fungi and to fully exploit them industrially. For that reason there is a demand for developing versatile methods that can be used to genetically manipulate non-model filamentous fungi. To facilitate this, we have developed a CRISPR-Cas9 based system adapted for use in filamentous fungi. The system is simple and versatile, as RNA guided mutagenesis can be achieved by transforming a target fungus with a single plasmid. The system currently contains four CRISPR- Cas9 vectors, which are equipped with commonly used fungal markers allowing for selection in a broad range of fungi. Moreover, we have developed a script that allows identification of protospacers that target gene homologs in multiple species to facilitate introduction of common mutations in different filamentous fungi. With these tools we have performed RNA-guided mutagenesis in six species of which one has not previously been genetically engineered. Moreover, for a wild-type Aspergillus aculeatus strain, we have used our CRISPR Cas9 system to generate a strain that contains an AACU_pyrG marker and demonstrated that the resulting strain can be used for iterative gene targeting.
C1 [Nodvig, Christina S.; Nielsen, Jakob B.; Kogle, Martin E.; Mortensen, Uffe H.] Tech Univ Denmark, Dept Syst Biol, Sect Eukaryot Biotechnol, Eukaryot Mol Cell Biol, DK-2800 Lyngby, Denmark.
RP Mortensen, UH (reprint author), Tech Univ Denmark, Dept Syst Biol, Sect Eukaryot Biotechnol, Eukaryot Mol Cell Biol, DK-2800 Lyngby, Denmark.
EM um@bio.dtu.dk
RI Hoof, Jakob Blasbjerg/L-6019-2015
OI Hoof, Jakob Blasbjerg/0000-0002-7650-9300
FU Danish Council for Strategic Research [11-116803]
FX This work was supported by Grant 11-116803 from The Danish Council for
   Strategic Research.
CR Aleksenko A, 1997, FUNGAL GENET BIOL, V21, P373, DOI 10.1006/fgbi.1997.0980
   Arnaud MB, 2012, NUCLEIC ACIDS RES, V40, pD653, DOI 10.1093/nar/gkr875
   BALLANCE DJ, 1983, BIOCHEM BIOPH RES CO, V112, P284, DOI 10.1016/0006-291X(83)91828-4
   Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39
   Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811
   BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984
   Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0
   Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714
   DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135
   Fleissner A, 2010, APPL MICROBIOL BIOT, V87, P1255, DOI 10.1007/s00253-010-2672-6
   Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808
   Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152
   GEMS D, 1991, GENE, V98, P61, DOI 10.1016/0378-1119(91)90104-J
   Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]
   Hansen BG, 2011, APPL ENVIRON MICROB, V77, P3044, DOI 10.1128/AEM.01768-10
   Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647
   Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501
   Jacobs JZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6344
   Jakounas T, 2015, METAB ENG, V28, P213, DOI 10.1016/j.ymben.2015.01.008
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Kaminskyj S.G.W., 2001, FUNG GENET NEWSL, V48, P25
   Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156
   Kitamoto N, 1998, APPL MICROBIOL BIOT, V50, P85, DOI 10.1007/s002530051260
   KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2
   Li Mamie Z, 2012, Methods Mol Biol, V852, P51, DOI 10.1007/978-1-61779-564-0_5
   Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7
   Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Moretti A, 2013, INT J FOOD MICROBIOL, V167, P57, DOI 10.1016/j.ijfoodmicro.2013.06.033
   Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817
   Nielsen ML, 2006, FUNGAL GENET BIOL, V43, P54, DOI 10.1016/j.fgb.2005.09.005
   Nissim L, 2014, MULTIPLEXED PROGRAMM
   Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21
   Nour-Eldin HH, 2010, METHODS MOL BIOL, V643, P185, DOI 10.1007/978-1-60761-723-5_13
   OHARA EB, 1989, GENETICS, V121, P249
   Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021
   Ruiz-Diez B, 2002, J APPL MICROBIOL, V92, P189, DOI 10.1046/j.1365-2672.2002.01516.x
   Ryan OW, 2014, ELIFE, V3, DOI 10.7554/eLife.03703
   Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842
   Tamano K, 2013, APPL MICROBIOL BIOT, V97, P269, DOI 10.1007/s00253-012-4193-y
   Wu F, 2014, ANNU REV FOOD SCI T, V5, P351, DOI 10.1146/annurev-food-030713-092431
   YUILL EDWARD, 1950, TRANS BRIT MYCOL SOC, V33, P324
   Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288
NR 46
TC 123
Z9 132
U1 15
U2 237
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 15
PY 2015
VL 10
IS 7
AR e0133085
DI 10.1371/journal.pone.0133085
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1RL
UT WOS:000358197600212
PM 26177455
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Bialk, P
   Rivera-Torres, N
   Strouse, B
   Kmiec, EB
AF Bialk, Pawel
   Rivera-Torres, Natalia
   Strouse, Bryan
   Kmiec, Eric B.
TI Regulation of Gene Editing Activity Directed by Single-Stranded
   Oligonucleotides and CRISPR/Cas9 Systems
SO PLOS ONE
LA English
DT Article
ID CELL-CYCLE PROGRESSION; DNA OLIGONUCLEOTIDES; MAMMALIAN-CELLS; SEQUENCE
   CORRECTION; CORRECTED CELLS; TARGETED REPAIR; GENOME; REPLICATION; CAS9;
   OLIGODEOXYNUCLEOTIDES
AB Single-stranded DNA oligonucleotides (ssODNs) can direct the repair of a single base mutation in human genes. While the regulation of this gene editing reaction has been partially elucidated, the low frequency with which repair occurs has hampered development toward clinical application. In this work a CRISPR/Cas9 complex is employed to induce double strand DNA breakage at specific sites surrounding the nucleotide designated for exchange. The result is a significant elevation in ssODN-directed gene repair, validated by a phenotypic readout. By analysing reaction parameters, we have uncovered restrictions on gene editing activity involving CRISPR/Cas9 complexes. First, ssODNs that hybridize to the nontranscribed strand direct a higher level of gene repair than those that hybridize to the transcribed strand. Second, cleavage must be proximal to the targeted mutant base to enable higher levels of gene editing. Third, DNA cleavage enables a higher level of gene editing activity as compared to single-stranded DNA nicks, created by modified Cas9 (Nickases). Fourth, we calculated the hybridization potential and free energy levels of ssODNs that are complementary to the guide RNA sequences of CRISPRs used in this study. We find a correlation between free energy potential and the capacity of single-stranded oligonucleotides to inhibit specific DNA cleavage activity, thereby indirectly reducing gene editing activity. Our data provide novel information that might be taken into consideration in the design and usage of CRISPR/Cas9 systems with ssODNs for gene editing.
C1 [Bialk, Pawel] Helen F Graham Canc Ctr, Gene Editing Inst, Newark, DC USA.
EM eric@geneeditinginstitute.com
FU National Institute of Health [5R01CA89325-12]
FX This work was supported by National Institute of Health
   [5R01CA89325-12]. The funder had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aarts M, 2011, GENE THER, V18, P213, DOI 10.1038/gt.2010.161
   Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537
   Bertoni C, 2005, HUM MOL GENET, V14, P221, DOI 10.1093/hmg/ddi020
   Bertoni C, 2009, NUCLEIC ACIDS RES, V37, P7468, DOI 10.1093/nar/gkp757
   Bibikova M, 2002, GENETICS, V161, P1169
   Bonner M, 2009, MUTAT RES-FUND MOL M, V669, P85, DOI 10.1016/j.mrfmmm.2009.05.004
   Brachman EE, 2005, DNA REPAIR, V4, P445, DOI 10.1016/j.dnarep.2004.11.007
   Brachman EE, 2002, CURR OPIN MOL THER, V4, P171
   Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624
   Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936
   Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218
   Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Davis L, 2014, P NATL ACAD SCI USA, V111, pE924, DOI 10.1073/pnas.1400236111
   Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011
   Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608
   Engstrom JU, 2008, CELL CYCLE, V7, P1402, DOI 10.4161/cc.7.10.5826
   Engstrom JU, 2009, BIOESSAYS, V31, P159, DOI 10.1002/bies.200800119
   Ferrara L, 2006, DNA REPAIR, V5, P422, DOI 10.1016/j.dnarep.2005.11.009
   Ferrara L, 2004, NUCLEIC ACIDS RES, V32, P5239, DOI 10.1093/nar/gkh822
   Ferrara L, 2007, DNA REPAIR, V6, P1529, DOI 10.1016/j.dnarep.2007.04.007
   Hu YL, 2005, MOL BIOTECHNOL, V29, P197, DOI 10.1385/MB:29:3:197
   Huen MSY, 2006, NUCLEIC ACIDS RES, V34, P6183, DOI 10.1093/nar/gkl852
   Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501
   Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766
   Liu J, 2010, J BIOL CHEM, V285, P23196, DOI 10.1074/jbc.M110.123844
   Liu L, 2002, MOL CELL BIOL, V22, P3852, DOI 10.1128/MCB.22.11.3852-3863.2002
   Majumdar A, 2003, J BIOL CHEM, V278, P11072, DOI 10.1074/jbc.M211837200
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Olsen PA, 2005, J GENE MED, V7, P1534, DOI 10.1002/jgm.804
   Olsen PA, 2005, GENE THER, V12, P546, DOI 10.1038/sj.gt.3302437
   Papaioannou I, 2009, J GENE MED, V11, P267, DOI 10.1002/jgm.1296
   Parekh-Olmedo H, 2007, GENE THER, V14, P1675, DOI 10.1038/sj.gt.3303053
   Pierce EA, 2003, GENE THER, V10, P24, DOI 10.1038/sj.3301857
   Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01
   Radecke F, 2004, J GENE MED, V6, P1257, DOI 10.1002/jgm.613
   Radecke F, 2006, MOL THER, V14, P798, DOI 10.1016/j.ymthe.2006.06.008
   Radecke S, 2006, J GENE MED, V8, P217, DOI 10.1002/jgm.828
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021
   Rivera-Torres N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096483
   ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096
   Strouse B, 2014, SCI REP-UK, V4, DOI 10.1038/srep03791
   Wu XS, 2005, P NATL ACAD SCI USA, V102, P2508, DOI 10.1073/pnas.0406991102
   YAMAMOTO T, 1992, GENETICS, V131, P811
   Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555
NR 48
TC 31
Z9 31
U1 1
U2 29
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 8
PY 2015
VL 10
IS 6
AR e0129308
DI 10.1371/journal.pone.0129308
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CK1GM
UT WOS:000355955300115
PM 26053390
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Yan, M
   Wen, J
   Liang, M
   Lu, YF
   Kamata, M
   Chen, ISY
AF Yan, Ming
   Wen, Jing
   Liang, Min
   Lu, Yunfeng
   Kamata, Masakazu
   Chen, Irvin S. Y.
TI Modulation of Gene Expression by Polymer Nanocapsule Delivery of DNA
   Cassettes Encoding Small RNAs
SO PLOS ONE
LA English
DT Article
ID VECTORS; SYSTEM; CCR5; CURE
AB Small RNAs, including siRNAs, gRNAs and miRNAs, modulate gene expression and serve as potential therapies for human diseases. Delivery to target cells remains the fundamental limitation for use of these RNAs in humans. To address this challenge, we have developed a nanocapsule delivery technology that encapsulates small DNA molecules encoding RNAs into a small (30nm) polymer nanocapsule. For proof of concept, we transduced DNA expression cassettes for three small RNAs. In one application, the DNA cassette encodes an shRNA transcriptional unit that downregulates CCR5 and protects from HIV-1 infection. The DNA cassette nanocapsules were further engineered for timed release of the DNA cargo for prolonged knockdown of CCR5. Secondly, the nanocapsules provide an efficient means for delivery of gRNAs in the CRISPR/Cas9 system to mutate integrated HIV-1. Finally, delivery of microRNA-125b to mobilized human CD34+ cells enhances survival and expansion of the CD34+ cells in culture.
C1 [Yan, Ming; Wen, Jing; Liang, Min; Chen, Irvin S. Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
   [Lu, Yunfeng] Univ Calif Los Angeles, Dept Biomol & Chem Engn, Los Angeles, CA 90095 USA.
   [Yan, Ming; Lu, Yunfeng] Univ Calif Los Angeles, Calif NanoSyst Inst CNSI, Los Angeles, CA 90095 USA.
   [Kamata, Masakazu] Univ Calif Los Angeles, David Geffen Sch Med, Dept Hematol Oncol, Los Angeles, CA 90095 USA.
   [Yan, Ming; Wen, Jing; Kamata, Masakazu; Chen, Irvin S. Y.] Univ Calif Los Angeles, AIDS Inst, Los Angeles, CA 90095 USA.
RP Chen, ISY (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
EM syuchen@mednet.ucla.edu
RI Wen, Jing/F-1949-2019; KAMATA, MASAKAZU/E-7550-2017
OI Wen, Jing/0000-0002-6127-6276; 
FU UCLA AIDS Institute; UCLA Center for AIDS Research [AI28697]; UCLA
   California NanoSystems Institute; NIH [R21 AI114433]
FX This work was supported by the UCLA AIDS Institute, the UCLA Center for
   AIDS Research (AI28697), the UCLA California NanoSystems Institute, and
   NIH R21 AI114433. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Al-Dosari MS, 2009, AAPS J, V11, P671, DOI 10.1208/s12248-009-9143-y
   An DS, 2007, P NATL ACAD SCI USA, V104, P13110, DOI 10.1073/pnas.0705474104
   Bousquet M, 2010, P NATL ACAD SCI USA, V107, P21558, DOI 10.1073/pnas.1016611107
   Castanotto D, 2002, RNA, V8, P1454, DOI 10.1017/S1355838202021362
   Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968
   Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006
   Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510
   Holkers M, 2014, NAT METHODS, V11, P1051, DOI [10.1038/nmeth.3075, 10.1038/NMETH.3075]
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Johnston SH, 2009, J VIROL, V83, P11016, DOI 10.1128/JVI.01242-09
   Jones CH, 2013, MOL PHARMACEUT, V10, P4082, DOI 10.1021/mp400467x
   Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006
   Klinman DM, 1997, J IMMUNOL, V158, P3635
   Li MJ, 2003, MOL THER, V8, P196, DOI 10.1016/S1525-0016(03)00165-5
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497
   O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108
   O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107
   Pang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096445
   Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021
   Rao DD, 2009, ADV DRUG DELIVER REV, V61, P746, DOI 10.1016/j.addr.2009.04.004
   Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048
   Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842
   Schiffer JT, 2012, J VIROL, V86, P8920, DOI 10.1128/JVI.00052-12
   Shimizu S, 2010, BLOOD, V115, P1534, DOI 10.1182/blood-2009-04-215855
   Shimizu Saki, 2009, Genet Vaccines Ther, V7, P8, DOI 10.1186/1479-0556-7-8
   So AYL, 2014, BLOOD, V124, P1502, DOI 10.1182/blood-2014-02-553842
   Wang JB, 2014, P NATL ACAD SCI USA, V111, P13157, DOI 10.1073/pnas.1410785111
   Wang WW, 2013, CURR PHARM BIOTECHNO, V14, P46
   Yan M, 2012, J AM CHEM SOC, V134, P13542, DOI 10.1021/ja304649a
   Yan M, 2010, NAT NANOTECHNOL, V5, P48, DOI [10.1038/nnano.2009.341, 10.1038/NNANO.2009.341]
   Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763
NR 34
TC 9
Z9 9
U1 1
U2 40
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 2
PY 2015
VL 10
IS 6
AR e0127986
DI 10.1371/journal.pone.0127986
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CJ7SJ
UT WOS:000355699100026
PM 26035832
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Forner, J
   Pfeiffer, A
   Langenecker, T
   Manavella, P
   Lohmann, JU
AF Forner, Joachim
   Pfeiffer, Anne
   Langenecker, Tobias
   Manavella, Pablo
   Lohmann, Jan U.
TI Germline-Transmitted Genome Editing in Arabidopsis thaliana Using
   TAL-Effector-Nucleases
SO PLOS ONE
LA English
DT Article
ID ZINC-FINGER NUCLEASES; SHOOT APICAL MERISTEM; DOUBLE-STRAND BREAKS;
   HOMOLOGOUS RECOMBINATION; FUNCTIONAL GENOMICS; HIGHLY EFFICIENT;
   GENE-THERAPY; FLORAL DIP; CELL FATE; DNA
AB Transcription activator-like effector nucleases (TALENs) are custom-made bi-partite endonucleases that have recently been developed and applied for genome engineering in a wide variety of organisms. However, they have been only scarcely used in plants, especially for germline-modification. Here we report the efficient creation of small, germline-transmitted deletions in Arabidopsis thaliana via TALENs that were delivered by stably integrated transgenes. Using meristem specific promoters to drive expression of two TALEN arms directed at the CLV3 coding sequence, we observed very high phenotype frequencies in the T2 generation. In some instances, full CLV3 loss-of-function was already observed in the T1 generation, suggesting that transgenic delivery of TALENs can cause highly efficient genome modification. In contrast, constitutive TALEN expression in the shoot apical meristem (SAM) did not cause additional phenotypes and genome re-sequencing confirmed little offtarget effects, demonstrating exquisite target specificity.
C1 [Forner, Joachim; Pfeiffer, Anne; Lohmann, Jan U.] Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Baden Wurttembe, Germany.
   [Langenecker, Tobias; Manavella, Pablo] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Baden Wurttembe, Germany.
RP Lohmann, JU (reprint author), Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Baden Wurttembe, Germany.
EM jlohmann@meristemania.org
OI Forner, Joachim/0000-0002-6406-7066; Pfeiffer, Anne/0000-0001-6825-6297;
   Lohmann, Jan/0000-0003-3667-187X
FU ERC [282139]
FX ERC grant 282139; erc.europa.eu. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391
   Arnould S, 2006, J MOL BIOL, V355, P443, DOI 10.1016/j.jmb.2005.10.065
   Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792
   Belhaj K, 2013, PLANT
   Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001
   Bibikova M, 2002, GENETICS, V161, P1169
   Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811
   Bush SM, 2010, PLANT PHYSIOL, V154, P25, DOI 10.1104/pp.110.159897
   Chen KL, 2013, J GENET GENOMICS, V40, P271, DOI 10.1016/j.jgg.2013.03.009
   Chou ST, 2012, DRUG FUTURE, V37, P183, DOI 10.1358/dof.2012.37.3.1779022
   Christian M, 2013, G3-GENES GENOM GENET, V3, P1697, DOI 10.1534/g3.113.007104
   Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717
   Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x
   De Buck S, 2009, PLANT J, V60, P134, DOI 10.1111/j.1365-313X.2009.03942.x
   de Felippes FF, 2012, PLANT J, V70, P541, DOI 10.1111/j.1365-313X.2011.04896.x
   de Pater S, 2013, PLANT BIOTECHNOL J, V11, P510, DOI 10.1111/pbi.12040
   ENGELKE DR, 1990, ANAL BIOCHEM, V191, P396, DOI 10.1016/0003-2697(90)90238-5
   Fauser F, 2012, P NATL ACAD SCI USA, V109, P7535, DOI 10.1073/pnas.1202191109
   Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114
   Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911
   FURNER IJ, 1992, DEVELOPMENT, V115, P755
   Ge XC, 2008, PLANT CELL REP, V27, P1341, DOI 10.1007/s00299-008-0561-6
   Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160
   Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504
   Ishige F, 1999, PLANT J, V18, P443, DOI 10.1046/j.1365-313X.1999.00456.x
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Katsuyama T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt638
   Lampropoulos A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083043
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199
   Lieberman-Lazarovich M, 2011, METHODS MOL BIOL, V701, P51, DOI 10.1007/978-1-61737-957-4_3
   Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009
   Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547
   Ohyama K, 2009, NAT CHEM BIOL, V5, P578, DOI 10.1038/nchembio.182
   Osakabe K, 2010, P NATL ACAD SCI USA, V107, P12034, DOI 10.1073/pnas.1000234107
   Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677
   Paques F, 2007, CURR GENE THER, V7, P49, DOI 10.2174/156652307779940216
   Pauwels K, 2014, NEW BIOTECHNOL, V31, P18, DOI 10.1016/j.nbt.2013.07.001
   ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096
   Sakuma T, 2014, DEV GROWTH DIFFER, V56, P2, DOI 10.1111/dgd.12111
   Schuster C, 2014, DEV CELL, V28, P438, DOI 10.1016/j.devcel.2014.01.013
   Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834
   Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630
   Sun N, 2014, MOL BIOSYST, V10, P446, DOI 10.1039/c3mb70412b
   Sun N, 2013, BIOTECHNOL BIOENG, V110, P1811, DOI 10.1002/bit.24890
   Uhde-Stone C, 2013, BIOL PROCED ONLINE, V15, DOI 10.1186/1480-9222-15-3
   Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106
   Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825
   Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179
NR 51
TC 20
Z9 22
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 30
PY 2015
VL 10
IS 3
AR e0121056
DI 10.1371/journal.pone.0121056
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CE9AD
UT WOS:000352134700087
PM 25822541
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Wang, WW
   Ye, CBH
   Liu, JJ
   Zhang, D
   Kimata, JT
   Zhou, P
AF Wang, Weiming
   Ye, Chaobaihui
   Liu, Jingjing
   Zhang, Di
   Kimata, Jason T.
   Zhou, Paul
TI CCR5 Gene Disruption via Lentiviral Vectors Expressing Cas9 and Single
   Guided RNA Renders Cells Resistant to HIV-1 Infection
SO PLOS ONE
LA English
DT Article
ID IMMUNODEFICIENCY-VIRUS TYPE-1; ONE-STEP GENERATION; T-CELLS; GENOME;
   NUCLEASE; CRISPR/CAS9; MICE; INDIVIDUALS; DISTINCT; ALLELES
AB CCR5, a coreceptor for HIV-1 entry, is a major target for drug and genetic intervention against HIV-1. Genetic intervention strategies have knocked down CCR5 expression levels by shRNA or disrupted the CCR5 gene using zinc finger nucleases (ZFN) or Transcription activator-like effector nuclease (TALEN). In the present study, we silenced CCR5 via CRISPR associated protein 9 (Cas9) and single guided RNAs (sgRNAs). We constructed lentiviral vectors expressing Cas9 and CCR5 sgRNAs. We show that a single round transduction of lentiviral vectors expressing Cas9 and CCR5 sgRNAs into HIV-1 susceptible human CD4(+) cells yields high frequencies of CCR5 gene disruption. CCR5 gene-disrupted cells are not only resistant to R5-tropic HIV-1, including transmitted/founder (T/F) HIV-1 isolates, but also have selective advantage over CCR5 gene-undisrupted cells during R5-tropic HIV-1 infection. Importantly, using T7 endonuclease I assay we did not detect genome mutations at potential off-target sites that are highly homologous to these CCR5 sgRNAs in stably transduced cells even at 84 days post transduction. Thus we conclude that silencing of CCR5 via Cas9 and CCR5-specific sgRNAs could be a viable alternative strategy for engineering resistance against HIV-1.
C1 [Wang, Weiming; Ye, Chaobaihui; Liu, Jingjing; Zhou, Paul] Chinese Acad Sci, Inst Pasteur Shanghai, Unit Antiviral Immun & Genet Therapy, Key Lab Mol Virol & Immunol, Shanghai 200025, Peoples R China.
   [Zhang, Di] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China.
   [Kimata, Jason T.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.
RP Zhou, P (reprint author), Chinese Acad Sci, Inst Pasteur Shanghai, Unit Antiviral Immun & Genet Therapy, Key Lab Mol Virol & Immunol, Shanghai 200025, Peoples R China.
EM blzhou@sibs.ac.cn
OI Kimata, Jason/0000-0002-0504-0090
FU Chinese National Science Foundation [31170871, 81161160569]; National
   Science and Technology Major Projects [2012ZX10001-008,
   2014ZX10001-001]; French Energy Company Areva; National Institutes of
   Health [AI106574]; Baylor-UTHouston CFAR [P30AI036211]
FX This work was supported by research grants from the Chinese National
   Science Foundation (31170871 and 81161160569), National Science and
   Technology Major Projects (2012ZX10001-008 and 2014ZX10001-001) and
   French Energy Company Areva to P.Z. and by research grants from National
   Institutes of Health to J.T.K. (AI106574) and the Baylor-UTHouston CFAR
   (P30AI036211). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Akkina R, 2003, ANTICANCER RES, V23, P1997
   Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591
   Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45
   Chelli M, 2001, J BIOL CHEM, V276, P46975, DOI 10.1074/jbc.M106432200
   Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507
   Cho SW, 2013, GENOME RES
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714
   Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856
   Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000
   Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI [10.1038/NMETH.2641, 10.1038/nmeth.2641]
   DiGiusto DL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000931
   Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095
   FREED EO, 1989, J VIROL, V63, P4670
   Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532
   HE JL, 1995, J VIROL, V69, P6705
   Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663
   Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905
   Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108
   Kothe DL, 2007, VIROLOGY, V360, P218, DOI 10.1016/j.virol.2006.10.017
   KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751
   Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777
   Levine BL, 2006, P NATL ACAD SCI USA, V103, P17372, DOI 10.1073/pnas.0608138103
   Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65
   Liu LH, 2013, J VIROL, V87, P1899, DOI 10.1128/JVI.01038-12
   Liu LH, 2011, J VIROL, V85, P8467, DOI 10.1128/JVI.00520-11
   Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5
   Maggio I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05105
   Maier DA, 2013, HUM GENE THER, V24, P245, DOI 10.1089/hum.2012.172
   Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Miller AD, 1996, J VIROL, V70, P5564
   Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597
   Nazari R, 2008, CURR GENE THER, V8, P264, DOI 10.2174/156652308785160674
   Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11
   Overbaugh J, 1996, AIDS RES HUM RETROV, V12, P107, DOI 10.1089/aid.1996.12.107
   Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410
   Ray N, 2006, CURR TOP MICROBIOL, V303, P97, DOI 10.1007/978-3-540-33397-5_5
   Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048
   Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0
   Shang H, 2011, J BIOL CHEM, V286, P14531, DOI 10.1074/jbc.M111.224527
   Shaw GM, 2012, COLD SPRING HARB PER, V2
   Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46
   Swan CH, 2006, GENE THER, V13, P1480, DOI 10.1038/sj.gt.3302801
   Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662
   Theodore TS, 1996, AIDS RES HUM RETROV, V12, P191, DOI 10.1089/aid.1996.12.191
   Tsai CJ, 2009, J NANOPART RES, V11, P1, DOI 10.1007/s11051-008-9474-0
   Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025
   Wen M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-79
   Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022
   Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111
   Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825
   Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166
NR 56
TC 8
Z9 12
U1 1
U2 30
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 26
PY 2014
VL 9
IS 12
AR e115987
DI 10.1371/journal.pone.0115987
PG 26
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AX9RO
UT WOS:000347239900125
PM 25541967
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Lawhorn, IEB
   Ferreira, JP
   Wang, CL
AF Lawhorn, Ingrid E. B.
   Ferreira, Joshua P.
   Wang, Clifford L.
TI Evaluation of sgRNA Target Sites for CRISPR-Mediated Repression of TP53
SO PLOS ONE
LA English
DT Article
ID TRANSCRIPTIONAL START SITES; SEQUENCE-SPECIFIC CONTROL; GENE-EXPRESSION;
   HUMAN-CELLS; MAMMALIAN-CELLS; CAS SYSTEM; RNA; ACTIVATION; DNA;
   ENDONUCLEASE
AB The CRISPR (clustered regularly interspaced short palindromic repeats) platform has been developed as a general method to direct proteins of interest to gene targets. While the native CRISPR system delivers a nuclease that cleaves and potentially mutates target genes, researchers have recently employed catalytically inactive CRISPR-associated 9 nuclease (dCas9) in order to target and repress genes without DNA cleavage or mutagenesis. With the intent of improving repression efficiency in mammalian cells, researchers have also fused dCas9 with a KRAB repressor domain. Here, we evaluated different genomic sgRNA targeting sites for repression of TP53. The sites spanned a 200-kb distance, which included the promoter, transcript sequence, and regions flanking the endogenous human TP53 gene. We showed that repression up to 86% can be achieved with dCas9 alone (i.e., without use of the KRAB domain) by targeting the complex to sites near the TP53 transcriptional start site. This work demonstrates that efficient transcriptional repression of endogenous human genes can be achieved by the targeted delivery of dCas9. Yet, the efficiency of repression strongly depends on the choice of the sgRNA target site.
C1 [Lawhorn, Ingrid E. B.; Ferreira, Joshua P.; Wang, Clifford L.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.
RP Wang, CL (reprint author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.
EM cliff.wang@stanford.edu
FU National Science Foundation Graduate Research Fellowship Program;
   Stanford Graduate Fellowship; National Institute on Aging
   [NIH-5R21AG040360-02]; National Institutes of Health S10 Shared
   Instrumentation [S10RR025518-01, S10RR027431-01]
FX IEBL was funded by the National Science Foundation Graduate Research
   Fellowship Program http://www.nsfgrfp.org/ and Stanford Graduate
   Fellowship http://sgf.stanford.edu/. IEBL, JPF, and CLW were funded by
   the National Institute on Aging (NIH-5R21AG040360-02)
   http://www.nia.nih.gov/. Data and sorting was performed on instruments
   in the Stanford Shared FACS Facility obtained using National Institutes
   of Health S10 Shared Instrumentation Grants S10RR025518-01 and
   S10RR027431-01 http://dpcpsi.nih.gov/orip/diic/shared_instrumentation.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140
   Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711
   Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520
   Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999
   Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001
   Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122
   Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886
   Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r
   Ferreira JP, 2013, P NATL ACAD SCI USA, V110, P11284, DOI 10.1073/pnas.1305590110
   Ferreira Joshua P, 2011, Syst Synth Biol, V5, P131, DOI 10.1007/s11693-011-9089-0
   Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623
   Gao XF, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku836
   Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044
   GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59
   Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869
   Hagmann M, 1997, J VIROL, V71, P5952
   Hao DL, 2005, ACTA BIOCH BIOPH SIN, V37, P779, DOI 10.1111/j.1745-7270.2005.00107.x
   Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501
   Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341
   Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916
   Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132
   Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]
   Mahmoudi S, 2009, MOL CELL, V33, P462, DOI 10.1016/j.molcel.2009.01.028
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749
   Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0
   Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673
   Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]
   Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022
   Saldana-Meyer R, 2011, EPIGENETICS-US, V6, P1068, DOI 10.4161/epi.6.9.16683
   Selby CP, 1997, NUCLEIC ACIDS RES, V25, P787, DOI 10.1093/nar/25.4.787
   Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764
   STEWART N, 1991, VIROLOGY, V180, P49, DOI 10.1016/0042-6822(91)90008-Y
   Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328
   Tsuchihara K, 2009, NUCLEIC ACIDS RES, V37, P2249, DOI 10.1093/nar/gkp066
   Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025
   Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886
   Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036
   Wu X, 2014, QUANT BIOL
   Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889
   Xu K., 2014, CELL MOL LIFE SCI
   Yamashita R, 2012, NUCLEIC ACIDS RES, V40, pD150, DOI 10.1093/nar/gkr1005
NR 47
TC 16
Z9 18
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 14
PY 2014
VL 9
IS 11
AR e113232
DI 10.1371/journal.pone.0113232
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AU4DF
UT WOS:000345558500142
PM 25398078
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Munoz, IM
   Szyniarowski, P
   Toth, R
   Rouse, J
   Lachaud, C
AF Munoz, Ivan M.
   Szyniarowski, Piotr
   Toth, Rachel
   Rouse, John
   Lachaud, Christophe
TI Improved Genome Editing in Human Cell Lines Using the CRISPR Method
SO PLOS ONE
LA English
DT Article
ID TAL EFFECTORS; DNA; SYSTEMS; CAS9; SPECIFICITY; NUCLEASES; NICKASES
AB The Cas9/CRISPR system become a popular choice for genome editing. In this system, binding of a single guide (sg) RNA to a cognate genomic sequence enables the Cas9 nuclease to induce a double-strand break at that locus. This break is next repaired by an error-prone mechanism, leading to mutation and gene disruption. In this study we describe a range of refinements of the method, including stable cell lines expressing Cas9, and a PCR based protocol for the generation of the sgRNA. We also describe a simple methodology that allows both elimination of Cas9 from cells after gene disruption and re-intoduction of the disrupted gene. This advance enables easy assessment of the off target effects associated with gene disruption, as well as phenotype-based structure-function analysis. In our study, we used the Fan1 DNA repair gene as control in these experiments. Cas9/CRISPR-mediated Fanl disruption occurred at frequencies of around 29%, and resulted in the anticipated spectrLlm of genotoxin hypersensitivity, which was rescued by re-introduction of Fan1.
C1 [Munoz, Ivan M.; Szyniarowski, Piotr; Toth, Rachel; Rouse, John; Lachaud, Christophe] Univ Dundee, Coll Life Sci, Med Res Council Prot Phosphorylat Unit, Dundee, Scotland.
RP Rouse, J (reprint author), Univ Dundee, Coll Life Sci, Med Res Council Prot Phosphorylat Unit, Dundee, Scotland.
EM j.rouse@dundee.ac.uk; c.lachaud@dundee.ac.uk
RI Perez, Franck/A-1558-2014
OI Perez, Franck/0000-0002-9129-9401; Munoz Munoz,
   Ivan/0000-0002-1606-5445; lachaud, christophe/0000-0003-2762-1619
FU Marie Curie Intra-European fellowship (FanDamAge); Medical Research
   Council (MRC); Medical Research Council [MC_U127070192, MC_UU_12016/1]
FX This work was supported by the Marie Curie Intra-European fellowship
   (FanDamAge) and the Medical Research Council (MRC). The pharmaceutical
   companies supporting the Division of Signal Transduction Therapy Unit
   (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck KgaA, Janssen
   Pharmaceutica and Pfizer) associated with the MRC PPU. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624
   Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714
   Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623
   Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004
   Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704
   MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021
   Makarova KS, 2011, J BACTERIOL, V193, P6039, DOI 10.1128/JB.05535-11
   Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577
   Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673
   Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460
   Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775
NR 17
TC 27
Z9 29
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 10
PY 2014
VL 9
IS 10
AR e109752
DI 10.1371/journal.pone.0109752
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AR6ZS
UT WOS:000343730400077
PM 25303670
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Cencic, R
   Miura, H
   Malina, A
   Robert, F
   Ethier, S
   Schmeing, TM
   Dostie, J
   Pelletier, J
AF Cencic, Regina
   Miura, Hisashi
   Malina, Abba
   Robert, Francis
   Ethier, Sylvain
   Schmeing, T. Martin
   Dostie, Josee
   Pelletier, Jerry
TI Protospacer Adjacent Motif (PAM)-Distal Sequences Engage CRISPR Cas9 DNA
   Target Cleavage
SO PLOS ONE
LA English
DT Article
ID NUCLEASE SPECIFICITY; ENDONUCLEASE CAS9; RNA; SYSTEMS; NICKASES; GENES;
   CELLS
AB The clustered regularly interspaced short palindromic repeat (CRISPR)-associated enzyme Cas9 is an RNA-guided nuclease that has been widely adapted for genome editing in eukaryotic cells. However, the in vivo target specificity of Cas9 is poorly understood and most studies rely on in silico predictions to define the potential off-target editing spectrum. Using chromatin immunoprecipitation followed by sequencing (ChIP-seq), we delineate the genome-wide binding panorama of catalytically inactive Cas9 directed by two different single guide (sg) RNAs targeting the Trp53 locus. Cas9: sgRNA complexes are able to load onto multiple sites with short seed regions adjacent to (5')NGG(3') protospacer adjacent motifs (PAM). Yet among 43 ChIP-seq sites harboring seed regions analyzed for mutational status, we find editing only at the intended on-target locus and one off-target site. In vitro analysis of target site recognition revealed that interactions between the 59 end of the guide and PAM-distal target sequences are necessary to efficiently engage Cas9 nucleolytic activity, providing an explanation for why off-target editing is significantly lower than expected from ChIP-seq data.
C1 [Cencic, Regina; Miura, Hisashi; Malina, Abba; Robert, Francis; Ethier, Sylvain; Schmeing, T. Martin; Dostie, Josee; Pelletier, Jerry] McGill Univ, Dept Biochem, Montreal, PQ, Canada.
   [Miura, Hisashi; Dostie, Josee; Pelletier, Jerry] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada.
   [Pelletier, Jerry] McGill Univ, Dept Oncol, Montreal, PQ, Canada.
RP Pelletier, J (reprint author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.
EM jerry.pelletier@mcgill.ca
FU Canadian Institutes of Health Research (CIHR) [MOP-106615, MOP-86716];
   CIHR [MOP-106530]; Richard and Edith Strauss Canada Foundation
FX This work is supported by the Canadian Institutes of Health Research
   (CIHR) to T.M.S. (MOP-106615) and J.D. (MOP-86716) and from CIHR
   (MOP-106530) and the Richard and Edith Strauss Canada Foundation to J.P.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Chiu H, 2013, GENETICS, V195, P1167, DOI 10.1534/genetics.113.155879
   Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714
   Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651
   Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808
   Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623
   Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044
   Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647
   Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Lefrancois P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-37
   Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298
   Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189
   Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]
   Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Malina A, 2013, GENE DEV, V27, P2602, DOI 10.1101/gad.227132.113
   Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001
   Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673
   Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021
   Rousseau M, 2014, NUCLEIC ACIDS RES, V42, P1524, DOI 10.1093/nar/gkt998
   Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002
   Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]
   Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011
   Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103
   Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025
   Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889
   Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016
   Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884
NR 33
TC 54
Z9 60
U1 0
U2 51
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 2
PY 2014
VL 9
IS 10
AR e109213
DI 10.1371/journal.pone.0109213
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AQ2BX
UT WOS:000342591500075
PM 25275497
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Fujita, T
   Fujii, H
AF Fujita, Toshitsugu
   Fujii, Hodaka
TI Identification of Proteins Associated with an IFN gamma-Responsive
   Promoter by a Retroviral Expression System for enChIP Using CRISPR
SO PLOS ONE
LA English
DT Article
ID CHROMATIN IMMUNOPRECIPITATION; STIMULATED TRANSCRIPTION;
   GENE-TRANSCRIPTION; ADAPTIVE IMMUNITY; NUCLEAR FACTOR; DNA CLEAVAGE;
   CELL-LINE; RNA; COMPLEX; INTERFERENCE
AB Isolation of specific genomic regions retaining molecular interactions is essential for comprehensive identification of molecules associated with the genomic regions. Recently, we developed the engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) technology for purification of specific genomic regions. Here, we developed a retroviral expression system for enChIP using CRISPR. We showed that the target genomic locus can be purified with high efficiency by using this system. We also showed that contamination of potential off-target sites is negligible by using this system if the guide RNA (gRNA) for the target site has a sufficiently long unique sequence in its seed sequence. enChIP combined with stable isotope labeling using amino acids in cell culture (SILAC) analysis identified proteins whose association with the interferon (IFN) regulatory factor-1 (IRF-1) promoter region increases in response to IFN gamma stimulation. The list of the associated proteins contained many novel proteins in the context of IFN gamma-induced gene expression as well as proteins related to histone deacetylase complexes whose involvement has been suggested in IFN gamma-mediated gene expression. Finally, we confirmed IFN gamma-induced increased association of the identified proteins with the IRF-1 promoter by ChIP. Thus, our results showed that the retroviral enChIP system using CRISPR would be useful for biochemical analysis of genome functions including transcription and epigenetic regulation.
C1 [Fujita, Toshitsugu; Fujii, Hodaka] Osaka Univ, Microbial Dis Res Inst, Combined Program Microbiol & Immunol, Suita, Osaka 565, Japan.
RP Fujii, H (reprint author), Osaka Univ, Microbial Dis Res Inst, Combined Program Microbiol & Immunol, Suita, Osaka 565, Japan.
EM hodaka@biken.osaka-u.ac.jp
RI Fujii, Hodaka/A-2420-2008; Fujii, Hodaka/N-9792-2019
OI Fujii, Hodaka/0000-0003-1296-4256; Fujii, Hodaka/0000-0003-1296-4256
FU Takeda Science Foundation; Uehara Memorial Foundation; Kurata Memorial
   Hitachi Science and Technology Foundation; Adaptable & Seamless
   Technology Transfer Program through Target-driven R&D (A-STEP) by the
   Japan Science and Technology Agency (JST) [AS251Z01861Q]; Ministry of
   Education, Culture, Sports, Science and Technology of Japan [25830131,
   23118516, 25118512]
FX This work was supported by Takeda Science Foundation
   (http://www.takeda-sci.or.jp) (T. F.), the Uehara Memorial Foundation
   (http://www.ueharazaidan.or.jp) (H. F.), the Kurata Memorial Hitachi
   Science and Technology Foundation
   (http://www.hitachi-zaidan.org/global/kurata/) (T. F. and H. F.),
   Adaptable & Seamless Technology Transfer Program through Target-driven
   R&D (A-STEP) by the Japan Science and Technology Agency (JST)
   (http://www.jst.go.jp/tt/EN/univ-ip/a-step.html) (#AS251Z01861Q) (H.
   F.), Grant-in-Aid for Young Scientists (B) (#25830131) (T. F.),
   Grant-in-Aid for Scientific Research on Innovative Areas "Cell Fate"
   (#23118516) (T. F.), "Transcription Cycle" (#25118512) (H. F.) from the
   Ministry of Education, Culture, Sports, Science and Technology of Japan
   (http://www.mext.go.jp/english/). The funders had no role in study
   design, data collection and analysis, decision to publish or preparation
   of the manuscript.
CR Aprile-Garcia F, 2014, ENDOCR CONNECT, V3, pR1, DOI 10.1530/EC-13-0079
   Baranello L, 2013, TRANSCRIPTION, V4
   Boisvert Francois-Michel, 2005, Sci STKE, V2005, pre2, DOI 10.1126/stke.2712005re2
   Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101
   Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886
   Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623
   Fujita T, 2013, ISRN BIOCH, V2013
   Fujita T, 2012, ADV BIOSCI BIOTECHNO, V3, P626, DOI DOI 10.4236/ABB.2012.35081
   Fujita T, 2014, EFFICIENT ISOLATION
   Fujita T, 2007, NUCLEIC ACIDS RES, V35, P1007, DOI 10.1093/nar/gkl1138
   Fujita T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03171
   Fujita T, 2013, BIOCHEM BIOPH RES CO, V439, P132, DOI 10.1016/j.bbrc.2013.08.013
   Fujita T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026109
   Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109
   GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6
   Guenther MG, 2000, GENE DEV, V14, P1048
   GUILD BC, 1988, J VIROL, V62, P3795
   Gupta M, 2003, J BIOL CHEM, V278, P44935, DOI 10.1074/jbc.M307696200
   Hoshino A, 2009, J BIOSCI BIOENG, V108, P446, DOI 10.1016/j.jbiosc.2009.05.005
   Hoshino A, 2006, BIOCHEM BIOPH RES CO, V346, P1062, DOI 10.1016/j.bbrc.2006.06.026
   Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647
   Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501
   Ishaq M, 2009, J CELL BIOCHEM, V106, P296, DOI 10.1002/jcb.22004
   Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Keough R, 1999, GENOMICS, V62, P483, DOI 10.1006/geno.1999.6035
   KRETZSCHMAR M, 1994, CELL, V78, P525, DOI 10.1016/0092-8674(94)90429-4
   Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342
   LOZZIO CB, 1975, BLOOD, V45, P321
   Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577
   Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749
   Maruyama T, 2007, CLIN EXP IMMUNOL, V147, P164, DOI 10.1111/j.1365-2249.2006.03249.x
   MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895
   MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4
   NAKAJIMA K, 1993, FEBS LETT, V315, P129, DOI 10.1016/0014-5793(93)81148-S
   Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754
   Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100
   Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200
   Pal S, 2007, J CELL PHYSIOL, V213, P306, DOI 10.1002/jcp.21180
   Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673
   Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022
   RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z
   Sehgal Pravin B, 2013, JAKSTAT, V2, pe24860, DOI 10.4161/jkst.24860
   Shan L, 2013, ONCOGENE
   Sikorski EM, 2006, J BIOL CHEM, V281, P24423, DOI 10.1074/jbc.M602287200
   Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011
   Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4
   Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025
   Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886
   YU SF, 1986, P NATL ACAD SCI USA, V83, P3194, DOI 10.1073/pnas.83.10.3194
   Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0
   Zhang YX, 2003, NUCLEIC ACIDS RES, V31, P2168, DOI 10.1093/nar/gkg318
   ZHENG XM, 1990, NATURE, V344, P556, DOI 10.1038/344556a0
NR 58
TC 18
Z9 18
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 22
PY 2014
VL 9
IS 7
AR e103084
DI 10.1371/journal.pone.0103084
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AM0QO
UT WOS:000339551100086
PM 25051498
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Jia, HG
   Wang, N
AF Jia, Hongge
   Wang, Nian
TI Targeted Genome Editing of Sweet Orange Using Cas9/sgRNA
SO PLOS ONE
LA English
DT Article
ID ZINC-FINGER NUCLEASES; XANTHOMONAS-CITRI; TOBACCO PLANTS; TAL EFFECTORS;
   MUTAGENESIS; GENE; ARABIDOPSIS; RNA; SYSTEM; CAS9
AB Genetic modification, including plant breeding, has been widely used to improve crop yield and quality, as well as to increase disease resistance. Targeted genome engineering is expected to contribute significantly to future varietal improvement, and genome editing technologies using zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9/single guide RNA ( sgRNA) have already been successfully used to genetically modify plants. However, to date, there has been no reported use of any of the current genome editing approaches in sweet orange, an important fruit crop. In this study, we first developed a novel tool, Xcc-facilitated agroinfiltration, for enhancing transient protein expression in sweet orange leaves. We then successfully employed Xcc-facilitated agroinfiltration to deliver Cas9, along with a synthetic sgRNA targeting the CsPDS gene, into sweet orange. DNA sequencing confirmed that the CsPDS gene was mutated at the target site in treated sweet orange leaves. The mutation rate using the Cas9/sgRNA system was approximately 3.2 to 3.9%. Off-target mutagenesis was not detected for CsPDS-related DNA sequences in our study. This is the first report of targeted genome modification in citrus using the Cas9/sgRNA system-a system that holds significant promise for the study of citrus gene function and for targeted genetic modification.
C1 [Jia, Hongge; Wang, Nian] Univ Florida, Dept Microbiol & Cell Sci, Citrus Res & Educ Ctr, Lake Alfred, FL 33850 USA.
RP Wang, N (reprint author), Univ Florida, Dept Microbiol & Cell Sci, Citrus Res & Educ Ctr, Lake Alfred, FL 33850 USA.
EM nianwang@ufl.edu
FU Citrus Research and Development Foundation
FX This work was supported by the Citrus Research and Development
   Foundation. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39
   Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811
   Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x
   Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218
   Chen KL, 2013, J GENET GENOMICS, V40, P271, DOI 10.1016/j.jgg.2013.03.009
   Christian M, 2013, TARGETED MUTAGENESIS, pG3
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Curtin SJ, 2013, METHODS MOL BIOL, V1069, P25, DOI 10.1007/978-1-62703-613-9_3
   de Pater S, 2013, PLANT BIOTECHNOL J, V11, P510, DOI 10.1111/pbi.12040
   DING SW, 1995, J GEN VIROL, V76, P459, DOI 10.1099/0022-1317-76-2-459
   Febres V, 2011, CITRUS TRANSFORMATIO, DOI [10.5772/24526, DOI 10.5772/24526]
   Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623
   Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004
   Jia HG, 2007, PLANT CELL REP, V26, P1961, DOI 10.1007/s00299-007-0403-y
   Jia HG, 2006, TRANSGENIC RES, V15, P375, DOI 10.1007/s11248-006-0011-6
   Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654
   Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199
   Liu ZZ, 2003, PLANTA, V216, P824, DOI 10.1007/s00425-002-0934-y
   Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817
   Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655
   Qi Y, 2013, TARGETED DELETION IN, pG3
   Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650
   Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992
   Strauss A, 2013, MOL PLANT, V6, P1384, DOI 10.1093/mp/sst075
   Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304
   Sun Z, 2013, J INTEGR PLANT BIOL
   SWARUP S, 1992, MOL PLANT MICROBE IN, V5, P204, DOI 10.1094/MPMI-5-204
   Talon Manuel, 2008, Int J Plant Genomics, V2008, P528361, DOI 10.1155/2008/528361
   Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845
   Wendt T, 2013, PLANT MOL BIOL, V83, P279, DOI 10.1007/s11103-013-0078-4
   Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886
   Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119
   Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472
   Yan Q, 2012, MOL PLANT MICROBE IN, V25, P69, DOI 10.1094/MPMI-05-11-0121
   Zhang F, 2011, METHODS MOL BIOL, V701, P167, DOI 10.1007/978-1-61737-957-4_9
   Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107
   Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179
NR 41
TC 37
Z9 64
U1 3
U2 186
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 7
PY 2014
VL 9
IS 4
AR e93806
DI 10.1371/journal.pone.0093806
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AE7EP
UT WOS:000334159800053
PM 24710347
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Hwang, WY
   Fu, YF
   Reyon, D
   Maeder, ML
   Kaini, P
   Sander, JD
   Joung, JK
   Peterson, RT
   Yeh, JRJ
AF Hwang, Woong Y.
   Fu, Yanfang
   Reyon, Deepak
   Maeder, Morgan L.
   Kaini, Prakriti
   Sander, Jeffry D.
   Joung, J. Keith
   Peterson, Randall T.
   Yeh, Jing-Ruey Joanna
TI Heritable and Precise Zebrafish Genome Editing Using a CRISPR-Cas System
SO PLOS ONE
LA English
DT Article
ID ZINC-FINGER NUCLEASES; TARGETED GENE DISRUPTION; TALENS; ENDONUCLEASE;
   MUTAGENESIS; BACTERIA; ARCHAEA; CELLS
AB We have previously reported a simple and customizable CRISPR (clustered regularly interspaced short palindromic repeats) RNA-guided Cas9 nuclease (RGN) system that can be used to efficiently and robustly introduce somatic indel mutations in endogenous zebrafish genes. Here we demonstrate that RGN-induced mutations are heritable, with efficiencies of germline transmission reaching as high as 100%. In addition, we extend the power of the RGN system by showing that these nucleases can be used with single-stranded oligodeoxynucleotides (ssODNs) to create precise intended sequence modifications, including single nucleotide substitutions. Finally, we describe and validate simple strategies that improve the targeting range of RGNs from 1 in every 128 basepairs (bps) of random DNA sequence to 1 in every 8 bps. Together, these advances expand the utility of the CRISPR-Cas system in the zebrafish beyond somatic indel formation to heritable and precise genome modifications.
C1 [Hwang, Woong Y.; Kaini, Prakriti; Peterson, Randall T.; Yeh, Jing-Ruey Joanna] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA.
   [Hwang, Woong Y.; Kaini, Prakriti; Peterson, Randall T.; Yeh, Jing-Ruey Joanna] Harvard Univ, Sch Med, Dept Med, Boston, MA USA.
   [Fu, Yanfang; Reyon, Deepak; Maeder, Morgan L.; Sander, Jeffry D.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Mol Pathol Unit, Charlestown, MA USA.
   [Fu, Yanfang; Reyon, Deepak; Maeder, Morgan L.; Sander, Jeffry D.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA USA.
   [Fu, Yanfang; Reyon, Deepak; Sander, Jeffry D.; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.
   [Peterson, Randall T.] Broad Inst, Cambridge, MA USA.
RP Peterson, RT (reprint author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA.
EM peterson@cvrc.mgh.harvard.edu; jyeh1@partners.org
OI Hwang, Woong/0000-0002-0575-0033
FU National Institutes of Health [R01 GM088040]; NIH Director's Pioneer
   Award [DP1 OD006862, K01 AG031300, R01 CA140188]; Defense Advanced
   Research Projects Agency (DARPA) [W911NF-11-2-0056]; Jim and Ann Orr MGH
   Research Scholar award; Charles and Ann Sanders MGH Research Scholar
   award; MGH Claflin Distinguished Scholar Award
FX This work was supported by National Institutes of Health [R01 GM088040
   to JKJ and RTP, NIH Director's Pioneer Award DP1 OD006862 to JKJ, K01
   AG031300 to JRJY, R01 CA140188 to JRJY]; Defense Advanced Research
   Projects Agency (DARPA) [W911NF-11-2-0056 to JKJ]; the Jim and Ann Orr
   MGH Research Scholar award (JKJ); the Charles and Ann Sanders MGH
   Research Scholar award (RTP); and the MGH Claflin Distinguished Scholar
   Award (JRJY). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537
   Blackburn PR, 2013, ZEBRAFISH, V10, P116, DOI 10.1089/zeb.2013.9999
   Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518
   Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218
   Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45
   Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861
   DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135
   Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409
   Foley JE, 2009, NAT PROTOC, V4, P1855, DOI 10.1038/nprot.2009.209
   Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348
   Gupta A., 2013, GENOME RES
   Gupta A, 2012, NAT METHODS, V9, P588, DOI [10.1038/NMETH.1994, 10.1038/nmeth.1994]
   Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555
   Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939
   Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501
   Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398
   Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170
   Sander JD, NUCL ACIDS RES, V38, pW462
   Sander JD, BMC BIOINFORMATICS, V11, P543
   Sander JD, 2011, METHOD CELL BIOL, V104, P51, DOI 10.1016/B978-0-12-374814-0.00003-3
   Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934
   Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542
   Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005
   Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842
   Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864
   Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886
   Zhu C, 2011, DEVELOPMENT, V138, P4555, DOI 10.1242/dev.066779
   Zu Y, 2013, NAT METHODS, V10, P329, DOI [10.1038/NMETH.2374, 10.1038/nmeth.2374]
NR 35
TC 192
Z9 202
U1 1
U2 106
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 9
PY 2013
VL 8
IS 7
AR e68708
DI 10.1371/journal.pone.0068708
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 182JD
UT WOS:000321736900106
PM 23874735
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

EF